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"Although nature commences with reason and ends in experience it is necessary 
for us to do the opposite, that is to commence with experience and from this to 
proceed to investigate the reason." 
-Leonardo da Vinci 
[iii] 
Abstract 
Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) as an in situ Technique for 
Dissolution Studies 
Dissolution studies are critical tests for measuring the performance, or rate of release, of a 
drug product. There are many variables that affect the dissolution rate of the drug. Such 
variables may include characteristics of the active pharmaceutical ingredient (API) (e.g., 
particle size, crystal form, and bulk density), drug product composition (e.g., drug loading, 
and the identity, type, and levels of excipients), the drug product manufacturing process (e.g., 
compreSSIon forces, equipment), and the effects of stability storage conditions (e.g., 
temperature, humidity). Since dissolution has the ability to detect these variables, the 
regulatory agencies (i.e. FDA and EMEA) have placed great emphasis on the test. Moreover, 
the regulatory agencies have increased the monitoring and auditing of the dissolution test. 
A novel technique using in situ attenuated total reflection-infrared spectroscopy (ATR-IR) to 
monitor dissolutions of pharmaceutical drug products was developed. The accuracy of this 
technique is ±3% relative to HPLC. Salicylic acid calibrator tablets were studied and two 
over-the-counter (OTe) formulations containing acetaminophen, and/or acetylsalicylic acid 
were tested during the research. This novel approach was also used to analyze multiple 
components in a single tablet. For example, dissolution of the individual components of 
caffeine-free version of Excedrin® tablets, acetaminophen and acetylsalicylic acid were easily 
distinguished. 
[iv] 
Furthermore, the system has the capability of monitoring the drug transformations during 
dissolution. For instance, this technique was used to monitor the dissolution and hydrolysis of 
aspirin to salicylic acid. The ATR-IR system was found to have good sensitivity and can 
analyze samples as low as 0.03 mg/mL (2 x 10-4 M) based on the limit of detection ("LOD") 
studies. This will be discussed in details in chapter four. This technique allows deeper insight 
into spectroscopy, reaction analysis, kinetics and dynamics of the dissolution of active 
components in a pharmaceutical formulation. 
In addition, this novel system was used to support research related to the BP oil spill that 
occurred in the Gulf of Mexico during April 20th - June 3rd, 2010. Specifically, the system 
was used to study dispersion of oil in the presence of dishwashing soaps as preliminary 
models for commercial dispersants. Dawn® dishwashing soap was used because of its 
powerful claim to clean wildlife affected by oil spills. Dawn® specifically uses anionic 
surfactants, such as alkyl dimethyl amine oxide, to break down oil samples. These surfactants 
reduce the surface tension of water and can weaken the barrier that automatically forms 
between oil and water, allowing them to unnaturally mix. 
Furthermore, in recognition of the potential of this technique to be widely used in the 
pharmaceutical industry for drug dissolution studies, an instrument was designed and the 
design is presented as a chapter in this dissertation. Overall, this work has discovered and 
validated the use of ATR-IR as a technique for monitoring to dissolution and 
dissolution/hydrolysis reactions of pharmaceutical formulations. It has excellent potential for 
studies of the dissolution of tablets especially multi-component tablets and tablets with 
ingredients that undergo subsequent hydrolysis. 
[v] 
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Introduction and Literature Overview 
Dissolution is a critical test for measuring the performance of a pharmaceutical formulation. 
The overall performance of the drug pertains to the rate of release of the drug. There are many 
variables that affect the dissolution rate of the drug. Recently, the importance of the 
dissolution test has increased substantially as indicated by the high level of regulations 
imposed on the industry by the various health agencies around the world. Dissolution testing 
plays several important roles in the pharmaceutical industry. First, the test is a quality control 
tool that measures change in composition of the formulation. Some of the relevant changes 
the dissolution test is able to detect include 'changes caused by temperature, humidity and 
photosensitivity. Second, the test is also important for formulation development. During 
development of a drug product, the formulators use the dissolution test to distinguish between 
different variations of the drug product. Such variations may include characteristics of the 
active pharmaceutical ingredient (API) (e.g., particle size, crystal form, and bulk density), 
drug product composition (e.g., drug loading, and the identity, type, and levels of excipients) 
and the drug product manufacturing process (e.g., compression forces, equipment). In the 
pharmaceutical industry it is important to produce several variations of the drug product since 
these are needed to access the drugs' performance in clinical trials. From the clinical trials, 
the efficacy of the variants are distinguished and obtained. Third, once in vivo (clinical trials) 
data has been established for the drug product, a correlation between in vivo (human blood 
data)/in vitro (lab dissolution results) is made using the dissolution studies. 
[1 ] 
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Dissolution, as per the IUPAC, is defined as the mixing of two phases with the formation of 
one new homogeneous (Le. the solution) phase and is pharmaceutically defined as the rate of 
mass transfer from a solid surface into the dissolution medium or solvent under standardized 
conditions of liquid/solid interface, temperature and solvent composition. 1 It is a dynamic 
property that changes with time and explains the process by which a homogenous mixture of a 
solid or a liquid can be obtained in a solvent. It happens to chemically occur by the crystal 
break down into individual ions, atoms or molecules and their transport into the solvent.2 
Dissolution is controlled by the affinity between the solid substance and the solvent. 
Moreover, the dissolution rate plays an important role in the understanding the chemistry of 
solvation. The dissolution rate is defined as the amount of drug substance that goes into 
solution per unit time under standardized conditions of liquid/solid interface, temperature and 
solvent composition. 
In order for drug molecules to be transported into solution, they must detach from the solid 
surface and form solvated molecules. This phenomenon is known as solvation. Regardless of 
whether a solid is crystalline or amorphous, neighboring molecules are closely associated 
with each other though intermolecular forces. The dissolution process involves two main 
steps: the first step is the interaction between the solid and solvent molecules (solvation). The 
second step is the mass transport of solvated molecules to the bulk solution. Solubility 
controls the first step while transport controls the second. The first step of dissolution is 
considered a physico-chemical reaction. The solvation process is reversible, and solubility is 
I IUPAC, Compendium of Chemical Terminology, 2nd ed. (the "Gold Book") (1997). Online corrected version: 

(2006-) "dissolution". 

2 Dressman, J. J.; Kramer, J. K., Eds. Pharmaceutical Dissolution Testing; Taylor and Francis: Florida, 2005. 

[2] 
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reached when the reaction reaches equilibrium. The dissolution process can also be described 

by the Gibbs free energy equation shown below: 

(Equation 1) 

I::.G I::.H - TI::.S 
This reaction involves the breaking and formation of new intermolecular interactions. The net 
entropy is usually positive in dissolution since dissolution favors disorder. Moreover, the net 
enthalpy plays a crucial role in this equation. Dissolution is usually determined by the net 
enthalpy change. If the net enthalpy is less than or equal to zero, then the reaction will occur 
until all solid particles are dissolved. However, if the net enthalpy is positive, the reaction will 
occur until equilibrium is reached. In addition, the reaction rates in dissolution could be 
described kinetically by the following equations: 
(Equation 2) 
V KdDrug][Solvent] 
(Equation 3) 
Where V is the reaction rate, Ea is the activation energy, R is a constant and T is temperature. 
The rate of dissolution is governed by the slower step of the twp step process mentioned 
earlier. Therefore, at room temperature, the rate of solvation is so fast that equilibrium is 
[3] 
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typically instantaneous. The mass transport step is usually much slower and becomes the rate 
limiting step in the dissolution process. 3 
Next, this chapter of the thesis will focus the describing the history of dissolution testing 
which has led to many types of pharmaceutical dosage forms as well as different types of 
apparatus systems. Even though there is increased interest in this area, the techniques used for 
studying dissolution rates remain fairly constant. In fact, there are only a handful of 
instruments used to analyze and understand the dissolution rates of drugs. This chapter will 
also discuss the current techniques used for dissolution testing. 
Last but not least, a thorough literature search into the use of A TR-IR spectroscopy as a 
dissolution technique was made and will be discussed in this chapter. The research has found 
that FTIR imaging and NIR spectroscopy have been used to study dissolution testing. 
Although FTIR imaging utilizes the same spectroscopic region as the proposed research, it is 
more of qualitative test than a quantitative one. Furthermore, NIR was used to study 
dissolving reactions. The major weakness of the NIR region is that the absorption bands 
occurring there are the overtones of the fundamental bands residing in the mid-IR region. As a 
result, they are relatively weak and not clearly delineated. This makes quantitative 
calculations complex and calibration procedures quite laborious and not transferable from one 
instrument to another. This research focuses on the mid-IR region. The mid-IR spectral region 
is where most of the fundamental structural information is produced. Also, because molecules 
differ from each other by having different combinations of functional groups, their mid-IR 
spectra can be used to identify them and characterize their structure. 
3 Hanson, R; Gray, V. Handbook of Dissolution Testing, 3rd ed., Dissolution Technologies: Delaware, 2004. 
[4] 
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1.1 History 
The earliest theories of the dissolution were based on physicochemical properties. The earliest 
reference to dissolution dates back to 1897 when Noyes and Whitney published an article 
entitled, "The Rate of Solution of Solid Substances in Their Own Solution.,,4 Noyes and 
Whitney investigated the phenomenon of dissolution by using two slightly soluble substances; 
benzoic acid and lead chloride. They developed a rotating bottle technique coupled with a 
titration method to determine the dissolution rates of these two active drugs. Refer to Figure 
1-1 for a schematic diagram of the first dissolution apparatus. 
4 Noyes, Arthur A.; Whitney, Willis R. The rate of solution of solid substances in their own solutions. Journal of 
the American Chemical Society 1897,19(12),930-934. 
[5] 
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Figure 1-1 Dissolution apparatus: Noyes and Whitney (Ref 1) (Figure reproduced 
from bottle figure in article). 
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Noyes and Whitney determined that the velocity of the solution is proportional to the 
difference between the concentration of the saturated solution and that of the solution present 
at the moment in question. They determined the following dissolution rate equation as shown 
in the equation 4 below: 
(Equation 4) 
dx 
C (5 - x)dt 
where S represents the solubility of the substance (mg/mL), x the concentration (usually mg 
or mmol) at the expiration of the time t (seconds) and C is a constant. Integration of the 
equation above gives equation 5: 
(Equation 5) 
1 5 
C T loge (5 - x) 
In order to obtain values for C in the equation, the solubility or S of the substance must be 
known. In addition, Noyes and Whitney found that the dissolution rate is controlled by a thin 
layer of saturated solution that forms instantly around a solid particle. Also, the rate at which 
a solid substance dissolves in its own solution is proportional to the difference between the 
concentration of the solution and the concentration of the saturated solution. 
In 1904, Nemst and Brunner modified the Noyes-Whitney equation by applying Fick's law of 
diffusion.5 They were able to show a relationship between the dissolution rate constant and 
5 Nemst, W.; Brunner, E. Velocity of Reaction in Non-Homogeneous System. Physical Chemistry 1904, 47, 56­
102. 
[7) 
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the diffusion coefficient. Refer to equation 6. The equation for Fick's law of diffusion is 

shown below: 

(Equation 6) 

DS 
k - Vh 
where D represents the diffusion coefficient (cm2/s), S is surface area (cm2) of the diffusion 
layer, V the solution volume (mL) and h is the diffusion layer thickness (J.l.m). By applying 
Fick's law, equation 7 was derived as shown below where k is the intrinsic dissolution rate 
constant: 
(Eq uation 7) 
dx (DS)
- =k - (Cs-Ct)dt Vh 
Based on the equations discussed earlier, it is evident that certain properties of the drug are 
important when determining dissolution. These properties include the solubility, physical 
form, media and pH of the media. 
In the 1950' s the emphasis shifted from studying the effects of physicochemical properties of 
drugs on dissolution to correlation of dissolution to bioavailability (BA) of dosage forms. Oral 
bioavailability is a key pre-requisite for any orally administered drug to be systemically 
effective. The United States Food and Drug Administration (FDA) defines bioavailability 
according to 21 CFR 320 (§ 320.1) 6 as: the rate and extent to which the active ingredient or 
active moiety is absorbed from a drug product and becomes available at the site of action. 
For drug products that are not intended to be absorbed into the bloodstream, bioavailability 
6 Bioavailability and Bioequivalence Requirements. Code of Federal Regulations, Part 320, Title 21, 2003. 
[8] 
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may be assessed by measurements intended to reflect the rate and extent to which the active 
ingredient or active moiety becomes available at the site of action. This definition focuses on 
the processes by which the active ingredients or moieties are released from an oral dosage 
form and move to the site of action.7 The definition above focuses on the process by which 
the active drugs or ingredients are released from an oral dosage form and move to the site of 
action in the human body. As noted in the guidance document, bioavailability is documented 
by developing a systemic exposure profile. This profile can be achieved by measuring the 
concentration of active ingredients and its active metabolites over time in samples collected 
from the systemic circulation. Systemic circulation describes the part of the cardiovascular 
system within the human body which carries oxygenated blood away from the heart and 
returns deoxygenated blood back to the heart.s Bioequivalence (BE) also plays an important 
role when considering dissolution. As per the FDA, bioequivalence is defined in § 320.1 as: 
the absence of a significant difference in the rate and extent to which the active ingredient or 
active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available 
at the site of drug action when administered at the same molar dose under similar conditions 
in an appropriately designed study. Both bioequivalence and bioavailability focus on the 
release of a drug substance from a drug product and subsequent absorption in the system 
circulation. Moreover, this is the basis for pharmacokinetics. 
Pharmacokinetics may be simply defined as what the body does to the drug. It attempts to 
study the mechanisms of absorption and distribution of the administered drug, the rate at 
7 Guidance for Industry; Bioavailability and Bioequivalence Studies for Orally Administered Drug Products­
General Considerations 2003. U.S. Department ofHealth and Human Services, FDA [Online], 
http://www.fda.gov/cder/guidance/index.htm (accessed May 1,2011). 
[9] 
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which the drug begins and duration of the effect. Bioavailability and bioequivalence rely on 
pharmacokinetics measurements such as AVC and Cmax that reflect the systemic exposure. 
AVC is the area under the plasmalserumlblood concentration-time curve from time zero to 
time t, where t is the last time point with measurable concentration for individual formulation. 
Cmax measures the peak exposure by measuring the peak drug concentration obtained 
directly from the data without interpolation. 9 
In the 1950's, the scientific community focused its interests on dissolution as the rate process 
for controlling the absorption of active drugs into the bloodstream. In 1951 L.l. Edwards 
suggested that the analgesic activity of aspirin tablets can be manipulated by its rate of 
dissolution within the GI tract. lO Edwards studied the kinetics of the dissolution of aspirin in 
water at different pH's but over the same temperature range. The solubilities of aspirin were 
measured and diffusion rates were recorded at several concentrations. He determined that the 
diffusion coefficients are not independent of the concentration. Edwards suggested that the 
dissolution of an aspirin tablet in the stomach and intestine is the rate process controlling the 
absorption of the aspirin into the bloodstream. 
In 1960, Levy and Hayes used a beaker and a three blade stirrer to demonstrate that the 
incidence of GI irritation of different brands of aspirin is dependent on the dissolution rates of 
8 Wilding, I. Bioequivalence testing for locally acting gastrointestinal products: what role for gamma 

scintigraphy? Journal ojClintcal Pharmacology 2002,42(11), 1200-1210. 

9 Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products­

General Considerations 2003. U.S. Department of Health and Human Services, FDA [Online], 

http://www.fda.gov/cder/guidance/index.htm (accessed May 1, 2011). 

10 Edwards, L. J. Solution and diffusion of aspirin in aqueous media. Transactions ojthe Faraday Society 1951, 

47,1191-1210. 

[10J 
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the dosage forms.!! In other words, the dissolution rates were critical for the release of aspirin 
into the body and causing irritation. Thus, if the release profile is controlled then the irritation 
levels are controlled. During this period it was recognized that although disintegration was a 
critical process, de-aggregation was also essential for bioavailability. Disintegration is the 
process by which an object breaks down or loses it cohesive ability. De-aggregation J2 is the 
dispersion of particles and dislodgment of the granules. Usually, surfactant in solution helps 
in the de-aggregation process. Figure \-2 is an illustration of where disintegration and de-
aggregation occur in the dissolution process. The dissolution process occurs in three phases. 
In Phase I, the rate of dissolution is very slow as during this process solvent diffuses into the 
solid material (e.g., the pill) via a process called wetting. The initial period is called 
"mechanical lag". Also, during this phase the solid particles undergo disintegration and 
deaggregation. In Phase II, the solid particles are well dispersed into the solvent and the rate 
of dissolution is more rapid. This rate follows a zero order kinetics profile (rate = dxldt=k). 
This is followed by Phase III in which 1-2 % of the active ingredient is dissolved at a much 
slower rate. The slower rate is caused by particles that have not been properly wetted and 
have not been de-aggregated. In this simulated diagram, approximately 5 % of the active 
ingredient does not dissolve. While, this level of incomplete dissolution is unlikely to occur in 
a well formulated pill, this section of the diagram nicely represents a process by which some 
of the active ingredient never dissolves. Two primary factors preventing complete dissolution 
are occlusion and saturation. In occlusion, the active ingredient is so well aggregated that it is 
11 Levy, G.; Hayes, B. A., Physiochemical basis of the buffered acetylsalicylic acid controversy, New England 
JournalofAledicine, 1960,21,1053-1058. 
12 Liu, J.; Stewart, P. J. Deaggregation during the dissolution ofbenzodiazepines in interactive mixtures. Journal 
ofPharmaceutical Sciences 1998, 87(12),1632-1638. 
[11] 
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poorly wetted that dissolution is not accomplished during the time of the experiment. 
Alternatively, saturation may have occurred whereby the active ingredient has reached its 
thermodynamic limit of solubility which prevents complete dissolution. Equilibrium suggests 
that complete dissolution is difficult to achieve. Equilibrium is the condition of the system in 
which competing influences are balanced. 
[12] 
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Figure 1-2 Dissolution process 
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In 1978, Underwood and Cadwallader13 modified the Noyes-Whitney equation to take into 
consideration sink conditions. They showed that solubility plays an important role in 
dissolution. Sink conditions exist when the volume of the dissolution medium is three to ten 
times larger than the volume required to make a saturated solution of the solute. Thus, sink 
conditions exist when the concentration (C) of active drug in the medium at time t is much 
smaller than the saturation concentration (Cs). They revised the Noyes Whitney equation 
accordingly. "M" represents the mass of substance remaining to be dissolved, "A" represents 
the surface area of the drug exposed to the dissolution medium and "k" represents the intrinsic 
dissolution rate constant (dissolution constant). 
(Equation 8) 
dM 
- = -kA (Cs - C)dt 
Moreover, as the concentration of the solution increases, the equation predicts that dM/dt 
decreases. When the concentration of the saturated solution is much larger than the 
concentration of the drug (Cs» C) in the solvent at time t, then equation 9 is obtained. 
(Equation 9) 
dM 
- = -kACsdt 
Underwood and Cadwallader concluded that the overall dissolution rate increases with 
increasing dissolution rate constant (k), increased surface area (A) and increased solubility 
13 Underwood, F. L.; Cadwallader, D. E. Automated potentiometric procedure for studying dissolution kinetics 
of acidic drugs under sink conditions, Journal ofPharmaceutical Sciences 1978, 67(8), 1163-1167. 
[14] 
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(Cs). Therefore, by maintaining A and Cs as constants, the dissolution rate constant can be 
conveniently measured. 
Furthermore, they stated that the dissolution rate of a drug from a constant surface area under 
sink conditions should follow zero-order kinetics. For zero-order kinetics, a linear plot of 
[drug concentration] vs. time can be used to determine the rate (k). This value can be 
interpolated from the slope. However, when there is a much higher level of a solute such as of 
benzoic acid in solution, the dissolution rate decreased slightly as shown in Figure 1-3 and 
Figure 1-4 below. Underwood and Cadwallader document that a possible reason for this 
decrease is that the concentration of the buffering compounds in the dissolution medium could 
retard the dissolution of the solute, i.e., benzoic acid. As the concentration of benzoic acid in 
solution increases, there is competition for solvent. Also, the buffer pH decreased slightly as 
the benzoic acid dissolves, which could have decreased the pH of the diffusion layer adjacent 
to the solid benzoic acid particles and caused a decrease in the dissolution rate. 
[15] 
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Figure 1-3 	 Importance of sink conditions in dissolution: dissolution of benzoic 
acid at low concentrations: Underwood and Cadwallader (Ref 8) 
(Figure reproduced from figure-1 in article) 
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Figure 1-4 	 Importance of sink conditions in dissolution: dissolution of benzoic 
acid at higher concentrations: Underwood and Cadwallader (Ref 8) 
(Figure reproduced from figure-3 in article) 
1100 
12.00 
300 
Non-Linear at higher 
cone. -------... 
eo .0 120 150 
MINUTES 
-Dillmueion 01 HMoie acid from a nondui,.t~,,.ti", did 
in buff.,. (pH 6.2) CIl :rr'w 100 rpm. 
[171 

Seton Hall University 
As a consequence of the research that had occurred from late 1800' s to mid 1900' s, in 1970 
the first official dissolution test appeared in USP XVIII. The United States Pharmacopeia or 
USP14 is a non-governmental, official public standards-setting authority for prescription and 
over-the-counter medicines and other healthcare products manufactured or sold in the United 
States. USP also sets widely recognized standards for food ingredients and dietary 
supplements. They set standards for the quality, purity, strength, and consistency of these 
products which are critical to the public health. 
Increased interest in dissolution regulations continue to grow well into the 1970's. In fact, in 
1978 the FDA published the document entitled, "Guidelines for Dissolution Testing.,,15 The 
intention behind this publication was to combine and streamline the systems and processes of 
different laboratories. This was due to the fact that dissolution results were observed to have 
high variability and minor changes in the equipment parameters increased variability. The 
FDA realized that they needed more controls on the tolerances of the dissolution equipment 
so that results are more reproducible. Additionally, the FDA and USP introduced the idea of 
calibrator tablets. In 1978 the USP launched three calibrator tablets: Prednisone, Salicylic 
Acid and Nitrofurantoin. These calibrator tablets were used during the calibration of the 
instrument to validate that the dissolution bath is working as indicated. The calibrator tablets 
have known specification limits and the calibrations of the instruments have to be within 
14 United States Pharmacopeia, Home Page. h!!p:!lwww.usp.org/ (accessed May 1,2011) 

15 Guidance for Industry: Dissolution Testing oflmmediate Release Solid Oral Dosage Forms 1997. U.S. 

Department of Health and Human Services, FDA [Online], h!!p:!lwww.fda.gov/cder/guidance/index.htm 

(accessed May 1,2011). 
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those limits. To gam an appreciation of the complexity of the dissolution system and 
equipment parameters, an overview of the technology will be given in the next section. 
In 1995, the USP assigned unique numbers to the different dissolution apparatus that were 
available to the scientific community. Specifically, there are seven different types of 
dissolution equipment generally used. These are listed below in Table 1-1. 
[19] 
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Table 1-1 Dissolution apparatus in the pharmaceutical industry 
Dissolution Apparatus Number Dissolution Apparatus Name 
Apparatus 1 Basket 
Apparatus 2 IPaddle 
Apparatus 3 IReciprocating Cylinder 
Apparatus 4 I Flow Through Cell 
Apparatus 5 , Paddle over Disk 
Apparatus 6 
[20] 
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Apparatus 1 and 2 are most widely used in the pharmaceutical industry. As shown above the 
first instrument uses baskets method while the second one uses paddles. Figure \-5 is a 
schematic illustration of these two apparatuses. The apparatuses are comprised of a covered 
vessel, a metallic drive shaft, a motor to spin the shaft, a cylindrical basket (Apparatus 1) or a 
paddle (Apparatus 2), and a water bath or heated jacket capable of maintaining the 
temperature of the vessels at 37° ± 0.5°C. 
[21] 
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Figure 1·5 Schematic illustration of Apparatus 1 and Apparatus 2 (Reproduced 
from USP General Chapter on Dissolution <711» 
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Although the figures above appear simple in design, there are strict regulations for the 
specifications of each component of the apparatus and tolerances for each component are 
specified by USP <711>.16 Refer to Figure 1-6 and Figure 1-7 for schematic diagrams of the 
specifications set by the USP for Apparatus 1 and Apparatus 2, respectively. 
As a result of these regulations of the past fifty years, the number of USP monographs 
including dissolution monographs has exponentially increased. As shown in Figure 1-8, in 
1970, there were only twelve monographs. In May of 2011, there were 740 dissolution USP 
monographs. 17 18 19 
16 US Pharmacopoeia & National Formulary- USP General Chapter <711>: Dissolution, USP [Online], 

http://www.usp.org! (accessed May 1,2011). 

17 Cohen, J; Hubert, B; Leeson, L; Rhodes, C; Robinson, J; Roseman, T; Shefier, E. The Devlopment of USP 

Dissolution and Drug Release Standards. Pharmaceutical Research 1990, 7(10), 983-987. 

18 Dokoumetzidis, A; Macheras, P. A century of dissolution research: From Noyes and Whitney to the 

Biopharmaceutics Classification System. International Journal ofPharmaceutics 2006,321, I-II. 

19 US Pharmacopoeia & National Formulary- USP Monographs including dissolution (2011 summary), 

http://www.usp.org! (accessed May 1,2011). 
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Figure 1-6 	 USP Apparatus 1 Specifications (Reproduced from USP General 
Chapter on Dissolution <711» 
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Figure 1-7 USP Apparatus 2 specifications (Reproduced from USP General 
Chapter on Dissolution <711» 
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Figure 1-8 Monographs including dissolution in the United States Pharmacopeia (USP) 
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As a result of the high regulations and increased number of USP monographs including 
dissolution, this research will improve dissolution testing. Conventional ways of testing have 
been used for many years by the industry. Specifically, the UVNis and HPLC systems have 
gone through several stages of evolution but continue to be used as the standards. This 
research and technique will attempt to improve dissolution testing in several ways. First, this 
technique will allow for in-situ analysis which is very important when dealing with sensitive 
drug formulations. These sensitive formulations are susceptible to more sampling error when 
samples are withdrawn from the dissolution vessel. Second, FTIR spectroscopy can be 
advantageous to dissolution testing. Unlike UVNis spectroscopy which gives a single peak 
per active drug, FTIR spectroscopy can be sued to monitor drug release via monitoring of 
numerous functional groups. Moreover, FTIR spectroscopy can be used to track chemical 
transformations within the vessel. This will be discussed in chapter three ofthis thesis. Lastly, 
FTIR can be used to study multi-component drug formulations. 
[27] 
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1.2 Infrared Spectroscopy 
A brief overview is warranted. Infrared spectroscopy is the spectroscopy that deals with the 
infrared region, 14000 cm-! (714 nm) to 10 cm-! (lxl06 nm), of the electromagnetic spectrum. 
Moreover, the IR portion of the electromagnetic spectrum is divided into three regions; near-
infrared, mid-infrared and far-infrared. The near-infrared20 energy, approximately in the 
region between 14000-4000 cm-!, can excite overtone or harmonic vibrations. The mid­
infrared2! energy, approximately in the region between 4000 cm-! (2500 nm) to 400 cm-! 
(25000 nm), can be used to study the fundamental vibrations of structures. The far-infrared 
region, approximately in the region between 400-10 cm- l , can be used to study to rotations of 
structures. With IR spectroscopy, different functional groups adsorb at different IR bands or 
regions as shown in Table 1-2.22 Thus, this technique can help identify and even quantify 
organic and inorganic molecules. 
20 J. Workman Jr. Interpretive spectroscopy for near-infrared, The Handbook ofOrganic Compounds; Academic 

Press: California, 2001; pp 143-182. 

21 Heise, H. M.; Kupper, L.; Butvina, L. N. Attenuated total reflection mid-infrared spectroscopy for clinical 

chemistry applications using silver halide fibers. Sensors and Actuators B: Chemical1998, 51 (1-3), 84-91. 

22 Images and frequencies obtained from: http://wwwchem.csustan.edu/tutoriais/infrared.htm. (accessed May 1, 

2011). 
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Table 1-2 	 Absorption bands (Ref 22) (Reproduced from table of frequencies 
found on CSU Website link) 
! 
Bond Compound Type frequency range, cm'1 
C·H Alkanes 
2960-2850{s) stretch 
1470-1350(v} scissoring and bending 
CH3 Umbrella Deformation 1380{m-w} - Doublet· isopropyl, (·butyl 
C·H Alkenes 3080·3020(m) stretch 1000-675(s) bend 
C·H 
Aromatic Rings 3100·3000(m) stretch 
Phenyl Ring Substitution Bands 870-675(s) bend 
Phenyl Ring Substitution Overtones 2000-1600(w) ­ fingerprint region 
C·H Alkynes 3333-3267(s) stretch 700·61 O(b) bend 
C=C Alkenes 16BO.1640(m.w) stretch 
CsC Alkynes 2260-2100(wsh) stretch 
C=C Aromatic Rings 1600, 15OO(w) stretch 
CoO Alcohols, Ethers Carboxylic acids, Esters 1260-1000(5) stretch 
C-O Aldehydes, Ketones. Carboxylic acids, Esters 1760-1670(5) stretch 
O·H 
Monomeric -- Alcohols. Phenols 3640-3160{S.br) stretch 
Hydrogen-bonded .- Alcohols. Phenols 3600-32oo(b) stretch 
Carboxylic acids 3000-25OO(b) stretch 
N·H Amines 3500-3300(m) stretch 1650·15BO (m) bend 
CoN Amines 1340-1 020(m) stretch 
C=N Nitriles 2260-2220(v) stretch 
NOl Nitro Compounds 1660-15OO(s} asymmetrical stretch 1390·1260(s} symmetric al stretch 
[29] 
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The infrared spectrum of a sample can be obtained by passing a beam of infrared light through 
the sample. A Fourier transform instrument23 can be used to measure how much energy was 
absorbed by the sample over the entire wavelength range. The interferometer is a 
fundamentally different piece of equipment than a monochromater. The light passes through 
a beamsplitter, which sends the light in two directions at right angles. One beam goes to a 
stationary mirror then back to the beamsplitter. The other goes to a moving mirror. The 
motion of the mirror makes the total path length variable versus that taken by the stationary-
mirror beam. When the two meet up again at the beamsplitter, they recombine, but the 
difference in path lengths creates constructive and destructive interference: an interferogram: 
A mathematical function called a Fourier transform converts an intensity-vs.-time spectrum 
into an intensity-vs.-frequency spectrum. Refer to equation 10. A (r) and X (k) are the 
frequency domain and time domain points, respectively, for a spectrum ofN points. 
(Equation 10) 
" irkACr) = L XCk)expC-2n IV) 
The FT -IR system can produce both transmittance and absorbance spectrum. Refer to Figure 
1-9 for an illustration of the FT -IR system.24 The interferogram represents the light output as a 
function of mirror position. The FT-IR raw data is processed to give the actual spectrum of 
light output as a function of wavenumber. 
23 Smith, B.C. Fundamentals of Fourier Transform Infrared Spectroscopy; CRC Press: London, 1996; Chapter 4. 
24 Image obtained from http://mmrc.caItech.eduiFTIRlFTIRintro.pdf (accessed July 1, 2011). 
[30] 
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Figure 1-9 FT-IR system schematic (Ref 24) 
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1.3 Literature background: in situ ATR-IR and dissolution 
In the pharmaceutical industry there are two main oral dosage forms: tablets and capsules. 
These are immersed in an aqueous solution, and the concentration of the active ingredient is 
monitored as a function of time?S Unfortunately, dissolution testing provides limited 
information on chemical processes that take place within a dissolution vessel. This is due to 
the limited capabilities of the techniques that are used during dissolution. For instance, most 
dissolution analysis is carried out using Ultraviolet (UV)/ Visible (Vis) spectroscopy which 
only gives concentration as a function of time. HPLC is used to separate multi-component 
drugs but still utilizes UVNis detectors as the backbone. One of the challenges the industry is 
faced with is to increase an understanding of the mechanisms governing dissolution. The 
current approach relies heavily on a data-driven approach. The health authorities have 
challenged the pharmaceutical industry to understand dissolution and make the dissolution 
test more biologically relevant.26,27 To have a better understanding of dissolution, dissolution 
chemists need to explore other instruments and experiments that could give insight into what 
is happening inside of the vessel. Our research focuses on using A TR mid-infrared 
spectroscopy as an in situ technique to monitor and study the dissolution of pharmaceutical 
tablets. Moreover, this research will give more insight into the science behind dissolution. 
Specifically, this research will attempt to not only monitor dissolution profiles using FTIR but 
25 a) Dressman, J. J.; Kramer, J. K., Eds. Pharmaceutical Dissolution Testing; Taylor and Francis: Florida, 

2005; b) Hanson, R; Gray, V. Handbook of Dissolution Testing, 3rd ed., Dissolution Technologies: Delaware, 

2004. 

26 Tong, C.; D'Souza, S.S.; Parker, . Mirza, T. Commentary on AAPS workshop - Dissolution testing for the 

twenty-first century: Linking critical quality attributes and critical process parameters to clinically relevant 

dissolution. Pharmaceutical Research 2007, 24, 1603-1607. 

27 Tong, c.; Lozano, R.; Mao, Y., Mirza; T., Ldbenberg, R.; ).!ickerson, 8.; Gray, V.; Wang, Q. The value of in 

Vitro dissolution in drug development: A position paper from the AAPS in Vitro release and dissolution focus 

group. Pharmaceutical Technology 2009,33,52-64. 
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also try to explain certain reactions (i.e. transformation of a drug from one form to another-
hydrolysis) that are otherwise missed with UV /Vis spectroscopy. Literature research on this 
topic shows that attempts have been made to study dissolution using near-infrared 
spectroscopy and infrared imaging. 
Attempts have been made to improve the characterization of the controlled release 
formulations by FT-IR imaging in ATR-IR mode.28 Van der Weerd and colleagues described 
the design and implementation of a new cell, which allows the study of drug release from 
tablets by macro-FT-IR ATR imaging with a diamond ATR accessory. The tablet formulation 
can be compacted directly on the A TR crystal. The authors explain that various components 
in the tablet can be determined FT-IR imaging. The described cell was applied to study a 
model tablet consisting of hydroxy propyl methylcellulose (HPMC) and caffeine. The study by 
Van der Weerd and co-workers demonstrate that the amount of drug rapidly decreases due to 
diffusion. Direct observation of this well know phenomenon is unattainable by dissolution 
techniques, but FT-IR imaging in ATR mode provides a means to achieve this. 
Moreover, Van der Weerd and Kazarian explored FT-IR imaging as a useful application for 
studying the distribution of different components in the tablet, e.g., drug, polymer and water 
as a function of time. It was shown that the release profile obtained by FT-IR imaging is 
comparable to that obtained by the flow-through dissolution test with UV spectroscopic 
28 a)Van der Weerd, 1.; Kazarian, S. G. Combined approach ofFTIR imaging and conventional dissolution tests 
applied to drug release. Journal Controlled Release 2004,98,295-305. b) Van der Weerd, 1.; Chan, K. L. A.; 
Kazarian, S.G. An innovative design of compaction cell for in situ FT-IR imaging of tablet dissolution. 
Vibrational Spectroscopy 2004,35(1-2),9-13. 
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detection. In addition, FT -IR imaging was also used to investigate the release of a poorly 
soluble drug from pharmaceutical tablets?9 
Blanc030 and co-workers investigated the use of near-infrared as a tool to study the dissolution 
profiles in pharmaceutical tablets. Their determination was based on the application of Partial 
Least-Squares 2 (PLS2) multivariate calibration models to NIR spectra for individual tablets. 
Marcelo and his colleagues documented that the proposed NIR method provides accurate 
predictions of dissolution profiles. In fact, the coefficient of correlation between the 
dissolution profiles obtained with it and a reference method exceeded 0.99 (r) in all cases, and 
calibration and prediction errors fell within acceptable ranges (6-7%). They conclude that the 
method allows the entire dissolution profile of intact pharmaceutical tablets to be determined 
in a simple, clean, expeditious manner without the need to use any reagents or solvents, or the 
production of any waste. 
In addition, Chan3l and co-workers investigated the use of FT-IR imaging as a tool to study 
formulations of ibuprofen in poly(ethylene glycol) (PEG) enabled characterization of the 
distribution of both polymer and drug in the tablet. The authors attempted to study the 
mechanism of dissolution and drug release for two tablet preparation methods: mechanical 
mixing and melt extrusion. The mechanisms of dissolution were compared using this 
spectroscopic imaging approach and found it to be very informative. 
29 a)Van der Weerd, J.; Kazarian S. G. Release of poorly soluble drugs from HPMC tablets studied by FTIR 
imaging and flow-through dissolution tests. Journal ofPharmaceutical Science 2005, 94, 2096-2109. b) Vander 
Weerd, J.; Kazarian, S.G. Validation of macroscopic attenuated total reflection-Fourier transform infrared 
imaging to study dissolution of swelling pharmaceutical tablets. Applied Spectroscopy 2004,58(12), 1413-1419. 
30 Blanco, M.; Alcala, M.; Gonzalez, J. M.; Torras, E. Determination ofdissolution profiles in intact 
pharmaceutical tablets by NIR spectroscopy. The Journal ofProcess Analytical Technology 2006,3(5),25-29. 
31 Chan, K. L. A.; Kazarian, S.G. Dissolution of solid dispersions of ibuprofen studied by Fourier Transform 
infrared imaging. Polymeric Drug Delivery 2006, 203-214. 
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Dissolution of salicylic acid, acetylsalicylic acid and 
acetaminophen using In Situ A TR-IR spectroscopy 
This chapter focuses on describing the application of in situ attenuated total reflectance-
infrared spectroscopy (ATR-IR) as a technique for measuring and studying dissolution of 
pharmaceutical formulations products. The majority of the methods for monitoring 
dissolutions utilize UV-Vis spectroscopy. For example, aliquots are manually withdrawn and 
analyzed by UV-Vis spectroscopy or HPLC with UV-Vis detection. However, the sampling 
process is disruptive to the dissolution profile since removal of aliquots from the vessel 
disturbs the solution. In addition, there are instruments that allow real-time analysis using in 
situ UV-Vis probes. For example, fiber optic dissolution testing is used in the industry to 
monitor pharmaceutical drug product release. Fiber optic dissolution is also used for 
formulation development.32 Formulators are using in situ UVNis systems to profile and 
develop drugs faster. Instead of relying on conventional techniques where dissolutions are 
conducted manually and analyzed offline, the advantage of the fiber optic system is that it 
allows for real-time data analysis. 
There is interest in the development of new methods that do not require manual sampling. 
Also, for multi-component formulations it is important to be able to observe the dissolution 
profile of each active pharmaceutical ingredient (API). Thus, there is also interest in the 
development of new spectroscopic methods that enable observation of multiple components. 
The use ATR-IR for analyzing aqueous samples is limited by the relatively high concentration 
32 Mirza, T.; Liu, Q.; Vivilecchia, R.; Joshi, Y. Comprehensive validation scheme for in situ fiber optics 
dissolution method for pharmaceutical drug product testing. Journal Pharmaceutical Science 2009, 98, 1086­
1094. 
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of analyte required for detection.33 Hence, this research investigated the use of ATR-IR as a 
technique for monitoring and understanding dissolution. Limit of detection (LOD) and limit 
of quantitation (LOQ) will play important roles in determining the sensitivity of the system. 
The LOD and LOQ values will be discussed in detail in chapter four of this thesis. Refer to 
equation II and 12 for the limit of detection and limit of quantitation calculations: 
(Equation 11) 
LOD = 3x (S~) 

(Equation 12) 
LOQ = lOx (S~) 
A TR spectroscopy is a sampling technique that is based on molecular vibration and the 
curvature of light beams when passing through different mediums. An A TR spectrum is 
generated by transmitting radiation, which can be IR (from 0.1 x 10-5 cm to 7.5 x 10-5 cm), 
VIS (from 7.0 x 10-5 to 4.0 X 10-5 cm), or UV (from 4.0 x 10-5 cm to 2.2 x 10-5 cm), through an 
optical crystal in contact with a sample and then determining what portion of the incident 
radiation is attenuated by the sample at a particular wavelength. 
With A TR sampling the IR beam is directed into a crystal of relatively higher refractive 
index. The IR beam reflects from the internal surface of the crystal and creates an evanescent 
wave, which projects orthogonally into the sample in intimate contact with the A TR crystal. 
Some of the energy of the evanescent wave is absorbed by the sample and the reflected 
33 Regan, F.; Meaney, M.; Yos, J. G.; Maccraith, B. D.; Walsh, J. E. Determination of pesticides in water using 
[36] 
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radiation (some now absorbed by the sample) is returned to the detector. The refractive 

indices of the crystal and sample are important considerations in the ATR sampling technique. 

Refer to equation 13: 

(Equation 13) 

where n2 is the refractive index of the sample, n 1 is the refractive index of the crystal and 8c 
is the critical angle. ATR spectrometry is used extensively in clinical assays, medical 
diagnostics, and laboratory testing.34 Since the depth of penetration for the evanescent wave 
in A TR spectrometry is shallow, there is a low incidence of Fresnel Reflection. Thus, reliable 
spectral analysis of murky, semisolid, turbid, and optically dense solutions is possible with 
ATR spectroscopy. Moreover, the A TR crystal is a relatively chemically resistant Zn-Se 
crystal that can be coated with an additional chemically resistant material which enables IR 
spectroscopy to be performed in aqueous solution. 
Therefore, in situ A TR-IR spectroscopy has the unique potential to simultaneously address 
problems associated with manual sampling and multi-component analysis discussed above. 
This is a potentially useful method for dissolution testing. Modern infrared instruments can be 
equipped with fiber optic probes containing A TR crystals that are chemically robust, provide 
excellent sensitivity and, with respect to in situ UV-Vis, are not affected by turbidity. In 
addition, since IR is very sensitive to specific functional groups, it has greater versatility in 
ATR-FTIR spectroscopy on PVC/chloroparaffin coatings. Analytical Chimica Acta 1996, 334, 85-92. 
34 Bynum, K.; Kassis, A. ATR Crystal Device. U.S. Patent 6,841,792, March 10,2002. 
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differentiating components in a multi-component mixture than UV-Vis spectroscopy.35 In this 
chapter, the successful development of dissolution tests using in situ ATR-IR spectroscopy to 
analyze single and multi-component mixtures is described. 
Since dissolution testing has evolved into a highly regulated activity in the pharmaceutical 
industry, health agencies have placed a greater emphasis on regulating dissolution methods. 
The dissolution test is the only one that can give an in vitro snapshot of how the drug product 
may behave in vivo. Because ofthis function, the number of dissolution methods in the United 
States Pharmacopeia (USP) has grown substantially. Furthermore, the U.S. Food and Drug 
Administration (FDA) has placed greater importance on the dissolution test. The FDA official 
website is full of material related to dissolution testing from guidance documents to warning 
letters.36 Thus, the potential impact of a new analytical technique that permits in situ analysis 
of multiple active ingredients is large. 
2.1 Experimental section 
2.1.1 Chemical and materials 
Acetaminophen reference material (batch no. 104KO154) was purchased from Sigma-Aldrich 
(St. Louis, MO, USA). Salicylic acid reference material (batch no. 04708HE) was purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Acetaminophen tablets (Tylenol® batch no. 
SLA175) were purchased from a local pharmacy. Excedrin® Caplets (Back and Body Brand, 
Lot #10067371: Acetaminophen 250 mg, Aspirin 250 mg) were purchased from a local 
pharmacy. Salicylic acid calibrator tablets (USP batch no. QOD200) were purchased from the 
35 Skoog, D.; Holler 1.; Crouch S. Principles ofInstrumental Analysis, 6th ed; Thomson Books, 2007; pp. 455­
480. 

36 United States Food and Drug Administration Home Page. http://www.fda.gov/ (accessed May 1,2011) 

[38J 
Seton Hall University 
USP. Methanol, acetone and acetonitrile (HPLC grades) were purchased from Pharmaco­
Aaper. Sodium hydroxide (batch no. 064214BH), used to prepare the pH buffered solutions, 
was purchased from Sigma-Aldrich (St. Louis, MO, USA). These analytes were selected 
because of their immediate release properties and high solubilities in phosphate buffers. 
Potassium phosphate monobasic (batch no. 103K0060), used to prepare the pH buffered 
solutions, was purchased from Sigma-Aldrich. Glacial acetic acid was purchased from Sigma 
Aldrich (St. Louis, MO, USA). All solutions were prepared using water treated by a Milli-Q 
Millipore purification system. All purified water aliquots have resistivity of not less than 18 
MOhm-cm-1. 
2.1.2 Instrumentation 
Samples were tested using Mettler Toledo's iC10 FT-IR system using a fiber optic probe 
equipped with a 1 mm diamond coated A TR probe. The IR system was operated by Mettler 
Toledo's iC IR version 3.0 or 4.0 software. pH determinations were carried out using a pH 
meter from VWR (model no. Symphony SB70P). HPLC analysis was carried out using two 
systems: Hewlett Packard 1 050 (operated by ChemStation) and Waters 2695 (operated by 
Empower). All UV measurements were carried out using a Hewlett Packard UV instrument 
(model no. 8452A diode array). The UV instrument was operated using HP's Softer-Olis 
Spectralworks. All manual dissolutions were tested using a Vankel Dissolution Bath (model 
no. 700). All analytical weight measurements were carried out using Mettler Toledo's 
DeltaRange and AG204 DeltaRange top loading balance. 
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2.1.3 Buffered solutions 
The pH 5.8 (200 mM) and 7.4 (50 mM) phosphate buffered solutions were prepared with 
monobasic potassium phosphate in accordance with the USP. As described in the USP, the 
detailed procedure for preparing these buffers is shown below.37,38 
Phosphate Buffered Solution: 
The volumes shown in the table are for 200 mL of buffer solution. Note: Where water is 
specified for solution or dilution of test substances in pH determinations, use carbon dioxide-
free water. 
• 	 Sodium Hydroxide Solution (0.2 M) - Dissolve 4.0 g of sodium hydroxide in water to 
make 100 mL. 
• 	 Monobasic Potassium Phosphate Solution (0.2 M) - Dissolve 27.22 g of monobasic 
potassium phosphate (KH2P04) in water, and dilute with water to 1000 mL. 
Table 2-1 	 Phosphate buffer preparations as per United States Pharmacopeia 
(USP) 
Composition of Standard Buffer Solutions 
Phosphate Buffer 
Place 50 ml of the monobasic potassIUm phosphate soluDon in a 200-ml volumetric ftask, add the specified volume of the sodium hydroxide 
solution, then add waterto voume. 
pH 5.8 6.0 6.2 6.4 6.6 6.8 70 72 74 7.6 7.8 8.0 
02 IV NaOH, mL 3.6 5.6 81 11 6 16.4 224 29.1 34.7 39.1 42.4 44.5 461 
2.1.4 Dissolution experiments 
Single component analysis: 300 mg salicylic acid tablets were tested in pH 7.4 phosphate 
buffered solutions. Dissolution was conducted using a vessel volume of 500 mL and at 
ambient temperature. All dissolutions were conducted using USP Apparatus II (paddles) with 
an agitation speed of 100 rpm. The dissolution run time was seven hours and thirty minutes. 
37 US Pharmacopoeia & National Formulary- USP Monograph: Salicylic Acid Tablets, USP [Online], 
http://www.usp.org/ (accessed May 1,2011). 
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Multi-tablet analysis: 300 mg salicylic acid and 500 mg acetaminophen tablets were tested in 
pH 5.8 phosphate buffered solutions. Dissolution was conducted using a vessel volume of 500 
mL and at ambient temperature. All dissolutions were conducted using USP Apparatus II 
(paddles) with an agitation speed of 50 rpm (a slower rpm was chosen to enable a slower rate 
of dissolution to help distinguish the components). The dissolution run time was six hours. 
Multi-component analysis: Three Excedrin® tablets, each composed of 250 mg aspirin 
(acetylsalicylic acid) and 250 mg acetaminophen were tested in pH 7.4 phosphate buffered 
solutions. Dissolution was conducted using a vessel volume of 500 mL and at ambient 
temperature. All dissolutions were conducted using USP Apparatus II (paddles) with an 
agitation speed of 100 rpm. The dissolution run time was one hour and thirty minutes. 
2.1.5 HPLC analysis 
The single-component analysis experiment was performed using the following HPLC 
parameters: HP 1050 HPLC, Waters Symmetry 300 CI8 5 /lm column (4.6 x 50 mm), mobile 
phase was 60/40/1 (water/ methanol/glacial acetic acid), flow rate was 2.0 mLimin, isocratic 
mode, injection volume was 5 /lL and absorbance was set at 296 nm. 
The multi-tablet analysis experiment was analyzed using the following HPLC parameters: 
Waters 2695, Waters Symmetry Shied RP CI8 3 /lm column (3.5 x 50 mm), mobile phase 
was 70/30/1 (water/ acetonitrile/trifluoroacetic acid (TF A», flow rate was 1.5 mLimin, 
isocratic mode, injection volume was 5 /lL and absorbance was set at 296 nm. 
38 US Pharmacopoeia & National Formulary- USP Monograph: Acetaminophen Tablets, USP [Online], 
-"=,-"-,-,,,-,-,-,,-,-,-,,,==(accessed May 1,2011). 
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The multi-component analysis experiment was performed using the following HPLC 
parameters: HP 1050 HPLC, Phenomenex Intersil ODS C 18 5 11m column (4.6 x 150 mm), 
mobile phase was 60/40/1 (methanol! water/ trifluoroacetic acid (TF A)), flow rate was 1.0 
mLimin, isocratic mode, injection volume was 25 ilL and absorbance was set at 280 nm. 
2.1.6 ATR-IR analysis 
The ReactIRTM iC 10 FTIR instrument is composed of a Mercury-Cadmium-Telluride 
("MCT") detector (liquid nitrogen cooled) and the FiberConduit™. When sample 
measurements must be made at high speed or when IR throughput is low, the highly sensitive 
mercury cadmium telluride (MCT) detector provides the ability to scan faster than a DLaTGS 
detector while maintaining a constant IR response. The FiberConduit™ is comprised of 
flexible IR transparent silver chloride/silver bromide optical fibers. The fiber optic probe 
interface (AgX 9.5 mm x 1.5 m Fiber (Silver Halide)) contains a diamond tip-DiComp ATR 
crystal. The resolution was set to 4 wavenumbers. The optical range used by the system is: 
1900 cm"1 to 650 cm"l. The gain adjustment was set to normal (lx) and the apodization 
method was set to Happ-Genzel. The system uses compressed air (house air, filtered and 
dehumified) to purge the optics. 
For the single component testing, data treatment was carried out using the following 
methodology: The data was first subjected to baseline correction. An absorption band at 1388 
cm-! was selected for salicylic acid. The height was calculated using a baseline band 
correction set at 1370 cm- I . The ATR-IR system was configured to collect spectra every five 
minutes. 
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For multi-tablet testing, the data was first sUbjected to baseline correction. An absorption 
band at 1388 cm-1 and baseline band at 1370 cm-1 were selected to calculate the peak height 
1for salicylic acid. An absorption band at 1246 cm-1 and a baseline band of 1276 cm- were 
selected to calculate the peak height for acetaminophen. The ATR-IR system was configured 
to collect spectra every five minutes. 
For mUlti-component testing, the data was first subjected to baseline correction. An absorption 
band at 1388 cm-1 and a two-point baseline set at 1370 cm-1 and 1414 cm-1 were selected to 
calculate the peak area for aspirin (acetylsalicylic acid). An absorption band at 1246 cm-1 and 
a two-point baseline set at 1217 cm-1 and 1265 cm- l were selected to calculate the peak area 
for acetaminophen. The ATR-IR system was configured to collect spectra every three 
minutes. 
For all ATR-IR experiments, 256 scans were collected and co-added for each spectral point. 
On average, every spectral point, took about two-minutes to complete. For all testing, the 
calculated peak response was subjected to mathematical smoothing using the ielO software. 
The data was compared to reference standards measurements collected prior to start of the 
linearity and dissolution experiments. Dissolution data was plotted vs. time and all dissolution 
experiments were allowed to equilibrate in the buffer for at least half an hour prior to the start 
of a dissolution experiment. 
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2.2 Results and discussion 
2.2.1 Single-component analysis 
2.2.1.1 Linearity results for salicylic acid using pH 7.4 phosphate buffer 
Salicylic acid was thoroughly studied in pH 7.4 phosphate buffered solution as recommended 
by the USP. Since salicylic acid has a pKa of 2.97 it is almost completely ionized at 
physiologic pH 7.4. Thus, the ratio of salicylic acid: salicylate is approximately 1 :25,000. 
During the method development phase, linear dilutions of salicylic acid reference standards 
were prepared and analyzed using ATR-IR spectroscopy. The linearity experiments served 
two purposes; 1) they determined whether IR spectroscopy provided a linear response to the 
different concentrations of salicylic acid, and, 2) whether IR spectroscopy can be used for 
very low concentration levels of salicylic acid. Initially, eight levels of salicylic acid standards 
were prepared. Based on the IR spectra obtained, salicylic acid has an IR frequency of interest 
at 1388 cm- I (Figure 2-1). The linearity experiments were further analyzed using linear 
regression. Based on the analysis, it was determined that salicylic acid had excellent linear 
correlation using IR spectroscopy with a 0.997 correlation coefficient (r2). Linear regression 
for salicylic acid was calculated using the IR absorption band at 1388 cm-1 and subtracting the 
baseline absorption band at 1370 cm- I . A chart of the digitized data is attached in Appendix 
[A]. Since the IR system resolution was set to four, large data sets were obtained during the 
analysis. An example ofthe digitized data can be found in the appendix. 
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Figure 2-1 Salicylic acid spectra at different concentrations in pH 7.4 phosphate 
buffered solution. 
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Table 2-2 Method development summary for Salicylic Acid (Linearity and 
Dissolution results) 
i Method development parameter Typical Pharmaceutical Results 
Acceptance criteria 
Accuracy (mean) i 
- Difference between IR and HPLC Report value .2.1% I 
, Linearity (n :2: 6) ~'0.997- Correlation coefficient r;:: 0.990 
- Range(Linearity experiment) Specify range , 0.016- 0.1130 mg/ml 
i Limit of detection (LaD) Specify LaD 0.02 mg/ml 
Limit of quantitation (LaO) Specify LaO 0.08 mg/ml 
Precision (%RSD) I Relative standard deviation 0.2% 
(n:2:6), ::; 2.0% 
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2.2.2 Dissolution results for salicylic acid using pH 7.4 phosphate buffer 
The next part of method development phase was to determine the accuracy of A TR-IR 
spectroscopy as a technique for measuring dissolution rates of a drug. This was determined by 
comparing the IR spectroscopy results with HPLC results. Although the USP methods 
typically recommend vessel volumes of 900 mL, the dissolution vessels were filled with 500 
mL of pH 7.4 phosphate buffer in order to increase the signal-to-noise ratio. The purpose of 
this change was to detect very low concentrations (below 10%) of the active drug. Practically 
the laboratory is not interested in seeing 10% levels, but rather higher concentrations. 
Therefore, in order to test the limits of the system, the lower dissolution vessel volumes were 
used. Next, the paddle was lowered to the USP recommended position (25 ± 2 mm from the 
bottom of the vessel) and rotated at 100 rpm at ambient temperature. To minimize 
hydrodynamic effects, the A TR probe was inserted approximately 5 mm below the surface of 
the medium.39 The first thirty-minutes were used to establish the spectral baseline, the shaft 
was momentarily stopped and one salicylic acid (300 mg) tablet was dropped into the vessel. 
Rotation was resumed and IR data were acquired every five minutes for a period of seven 
hours. During this time, aliquot samples were removed and stored in HPLC vials for 
subsequent analysis. As shown in Figure 2-2, the results from the IR and HPLC systems 
match extremely well and the relative accuracy is within ± 2%. 
39 Mauger J. W. Physicochemical and fluid mechanical principles applied to dissolution testing. Dissolution 
Technologies, 1996,3,7-11. 
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Figure 2-2 	 Comparison of in situ ATR-IR and HPLC methods for dissolution of a 
salicylic acid tablet 
The dissolution plot below represents % dissolved of salicylic acid vs. time. This particular 
experiment was carried out over seven hours. The light blue diamond data points represent the 
A TR-IR results whereas the red squares represent the HPLC results. Moreover, as observed in 
the figure below, the IR data at approximately seven hours appears to be noisy. This is 
probably due to disturbance of the fiber optic probe during the HPLC sample collections at 
the seven-hour time points. 
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Table 2-3 	 % Dissolved of salicylic acid: Absolute % dissolved difference 
between ATR-IR and HPLC results 
This data represents the dissolution results for salicylic acid from Figure 2-2. The ATR-IR 
data was compared to the HPLC data and the absolute difference between both methods was 
calculated. The average difference was also calculated. 
Salicylic acid (HPLC) I Salicylic acid (ATR-IR) 
Time (h:mm) (% Dissolved) i (% Dissolved) 
0:00 0.0% 0.0% 
!11.1%0:30 
'---" 
1:00 20.9% 
2:00 38.2% 
3:00 52.9% 
6:00 87.8% 
7:00 94.8% 
14.4% 
23.1% 
38.0% 
50.9% 
93.8% 
97.8% 
Average 
Absolute Difference 

(%) 

0.0% 

3.3% 

2.2% 

-0.1% 

-2.0% 

6.0% 

3.0% 

2.1% 
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2.2.3 	 Multi-tablet analysis 
2.2.3.1 	 Linearity results for salicylic acid and acetaminophen in pH 5.8 
phosphate buffer 
The USP monograph specifies pH 5.8 phosphate buffer as the medium of choice for 
acetaminophen. Thus, acetaminophen and salicylic acid were thoroughly studied in pH 5.8 
phosphate buffer. As expected, regression analysis for salicylic acid indicated an excellent 
linear correlation (r = 0.994) of IR peak intensity vs. concentration. For acetaminophen, at 
low concentrations (~ 0.11 mg/ml, 0.7 mM), the relationship between absorbance and 
concentration is effectively linear (r2= 0.998). However, to our surprise, non-linear behavior 
for both IR and UV -Vis methods was observed at higher concentrations. As shown in Figure 
2-3, both methods can be modeled using second-order polynomial equations.4o 
40 Dejaegher, B.; Bloomfield, M.S.; Smeyers-Verbeke, J.; Heyden, Y. Validation of a Fluorimetric Assay for 4­
Aminophenol in Paracetamol Formulations. Talanta 2008, 75, 258-265. 
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-- .... ----------~-------------------------
Figure 2·3 	 Calibration curves of acetaminophen standards at pH 5.8: UVNis 
absorbance at 296 nm and IR peak intensity at 1246 cm-1 
Acetaminophen in pH 5.8 buffer is linear at the lower concentrations. During the early stage 
of dissolution, the concentration (C) of the active drug is much lower than the saturation 
concentration (Cs). However, as time progresses the solution becomes saturated at which 
point the drug will compete for solution space. Moreover, as more molecules of 
acetaminophen are in solution, more hydrogen bonding (between carbonyl and hydroxyl 
groups) will occur between the molecules potentially causing dimerization in solution. 
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2.2.3.2 	 Dissolution results for salicylic acid and acetaminophen in pH 5.8 
phosphate buffer 
To demonstrate the ability of in situ ATR-IR to successfully monitor dissolution of two 
different tablets, the dissolution profile of salicylic acid and acetaminophen tablets was 
determined by simultaneously adding one tablet of each and monitoring the dissolution rate of 
both components over seven hours. 
Although salicylic acid is not used clinically, it serves as an USP recommended standard for a 
slowly eroding tablet and acetaminophen serves as an example of a tablet that disintegrates. 
As shown in the figure below, the in situ ATR-IR method is clearly able to distinguish the 
dissolution of each component. For example, the acetaminophen tablet disintegrates and 
releases acetaminophen more rapidly than the salicylic acid tablet which slowly erodes over 
time. Thus, in situ ATR-IR method is successful in determining the dissolution profile of a 
two component system. 
To compare the in situ ATR-IR method with HPLC and UV-Vis methods, aliquots 
were taken throughout the experiment and analyzed. The results from the in situ ATR-IR and 
HPLC systems are overlaid in Figure 2-4 and an excellent correlation is observed between the 
two methods. In addition, samples were analyzed using a UV Nis instrument. Since both 
salicylic acid and acetaminophen absorb at approximately 296 nm (PH 5.8) it will not be ideal 
to monitor the dissolution of these two components using UV Nis alone. Moreover, extensive 
mathematical equations will be required to solve simultaneous equations in order to 
differentiate the two active drugs. 
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Figure 2-4 	 Simultaneous dissolution of acetaminophen and salicylic acid tablets: 
in situ A TR-IR vs. HPLC 
The dissolution plot below represents % dissolved of individual salicylic acid and 
acetaminophen tablets vs. time. Moreover, two separate tablets were inserted into a single 
vessel during the analysis. The dissolution was carried out at pH 5.8 phosphate buffer as 
suggested by the USP. This particular experiment was carried out over six hours. The red 
squares and yellow diamonds represent the HPLC data. As observed, the ATR-IR and HPLC 
results are very similar at the specified time-points shown below. Since acetaminophen tablets 
are designed to disintegrate rapidly, the drug release quickly as observed in the plot. Since 
salicylic acid is an eroding (slowly releasing) tablet, the drug releases slower as observed in 
the plot. In addition, the dissolution was carried out using an agitation speed of RPM. 
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2.2.4 	 Multi-component analysis 
2.2.4.1 	 Dissolution results for Excedrin® caplets (aspirin and acetaminophen) 
in pH 7.4 phosphate buffer 
To demonstrate the ability of in situ ATR-IR to successfully monitor multiple components 
within the same tablet, dissolution testing was carried out on Excedrin® caplets. The label 
claims for the Excedrin® caplet are acetylsalicylic acid (250 mg) and acetaminophen (250 
mg) actives. The release profile was determined by simultaneously adding three Excedrin® 
caplets to a 500 mL vessel volume containing pH 7.4 phosphate buffer. Three caplets were 
necessary to ensure satisfactory signal to noise ratio. Refer to Figure 2-5 for ATR-IR spectra 
for Excedrin® caplets. The dissolution rates of both components were monitored over 1.5 
hours. Based on the data, it was determined that acetylsalicylic acid and acetaminophen were 
fully released within 1.5 hours as shown in Figure 2-6. In situ A TR-IR method is clearly able 
to distinguish the dissolution the acetylsalicylic acid and acetaminophen components. 
To compare the in situ A TR-IR method with HPLC, aliquots were taken throughout 
the experiment and analyzed. The results from the in situ ATR-IR and HPLC systems are 
overlaid in Figure 2-6 and an excellent correlation is observed between the two methods. 
Refer to Table 2-4 to Table 2-7 for statistical values. Overall, this set of experiments indicates 
the versatility of in situ A TR-IR for dissolution testing as it allows automated observation of a 
multi-component system without manual sampling and by successfully tracking the 
dissolution behavior of two of the major components. 
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Figure 2-5 	 ATR-IR spectra of Excedrin® caplets at different time-points during 
dissolution in pH 7.4 phosphate buffered solution 
ATR-IR spectra for Excedrin® caplet (acetaminophen and acetylsalicylic acid) in pH 7.4 
phosphate buffer solution. Acetaminophen was calculated using wavenumber 1246 cm- I and 
acetylsalicylic acid was calculated using 1388 cm- I . 
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Figure 2-6 	 Dissolution of acetylsalicylic acid and acetaminophen in Excedrin® 
caplets: in situ ATR-IR VS. HPLC 
The figure below represents a plot of Excedrin® (acetaminophen and acetylsalicylic acid % 
dissolved) vs. time. The blue squares and yellow triangles represent the HPLC data points. As 
observed, the two techniques (lR and HPLC) correlate very well. Refer to Table 2-4 for more 
details. 
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Table 2-4 	 Dissolution of acetylsalicylic acid (aspirin) and acetaminophen in 
Excedrin® caplets: ATR-IR raw data 
Raw data results for the A TR-IR spectra of Excedrin® caplets. 
Acetaminophen (A TR-IR) Aspirin (ATR-IR) 
Time (h:mm:ss) (% Dissolved) (% Dissolved) 
.... 
0:00:00 0.0 0.0 
0:03:00 4.8 4.9 
0:05:59 13.7 13.6 
0:08:59 26.5 25.9 
0:11:59 41.6 39.8 
0:15:00 57.3 52.5 
0:17:59 69.0 65.6 
0:20:59 79.2 76.7 
0:23:59 86.8 86.1 
0:27:00 92.1 92.0 
0:29:59 95.8 96.8 
~.. 
0:32:59 98.2 99.2 
0:35:59 100.1 100.6 
0:38:59 100A 102.1 
0:41:59 99.3 102.2 
I 
0:44:59 99.0 100.2 
0:48:00 99.2 99.9 
0:50:59 98.9 99.7 
i 
0:53:59 99.3 99.5 
I 0:57:00 99.6 99.3 
0:59:59 100.0 100.0 
: 
I 1:02:59 99.2 100.0 
1:06:00 99.3 100.1 
1:08:59 98.9 99.9 
1 :12:00 98A 99.2 
1:14:59 97.6 98.9 
1 :17:59 97.9 98.9 
1 :20:59 98.1 98.8 
1:24:00 98.6 98.8 
1:26:59 98.0 99.2 
1:30:00 98.6 99.2 
[57] 
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Table 2-5 	 Dissolution of acetylsalicylic acid (aspirin) and acetaminophen in 
Excedrin® caplets: HPLC raw data 
1 £ Ed' ®Raw HPLCdata resu ts or xce rm caplets. 
I Time (h:mm:ss) 
0:00:00 
Acetaminophen (HPLC) 
(% Dissolv~d) 
0.0 
Aspirin (HPLC) 
(% Dissolved) 
0.0 
0:11:00 
0:30:00 
48.4 
95.7 
29.9 
98.6 
I 
1:00:00 98.0 100.7 I 
Table 2-6 % Dissolved of acetaminophen: Difference between ATR-IR and HPLC 
results 
Time I Acetaminophen (HPLC) Acetaminophen (ATR-IR) 
(h:mm:ss) I (% Dissolved) (% Dissolved) Absolute Difference 
0:00:00 I 0.0 0.0 0.0 
0:11:00 i 48.4 41.6 6.8 
0:30:00 I 95.7 95.8 -0.1 
1:00:00 I 98.0 100.0 -2.0 
Table 2-7 % Dissolved acetylsalicylic acid (aspirin) analysis: Difference between 
ATR-IR and HPLC results 
Time I Aspirin (HPLC) Aspirin (ATR-IR) 
(h:mm:ss) (% Dissolved) (% Dissolved) Absolute Difference 
0:00:00 0.0 0.0 0.0 
0:11:00 29.9 39.8 -9.9 
0:30:00 98.6 9~.8 1.8 
1:00:00 100.7 I 100.0 0.7 
[58] 
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Figure 2-7 Compounds studied/of interest for future work (Chern. Draw) 
This figure represents some of the compounds studied during the research (i.e. 
acetaminophen, aspirin). Also, other compounds and combinations of these compounds will 
be studied during future research. These potential compounds include ibuprofen, naproxen 
and caffeine. 
Ibuprofen Naproxen HOOC 
Acetmninopheuf Caffeine 
Acetmnillopheni Aspirini Caffeine 
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2.3 Chapter summary 
In situ infrared spectroscopy was found to be a viable alternative for measuring dissolution 
profiles of pharmaceutical tablets. The IR system was found to be impressive in its capability 
of measuring very low concentrations. The limit of detection was found to be 0.02 mg/ml per 
IUPAC calculations. The IR system was able to distinguish separate components of a mUltiple 
component system without requiring manual sampling. This versatility is demonstrated by 
observing the simultaneous dissolution of acetaminophen and salicylic acid tablets. In 
contrast, UV-Vis spectroscopy may require mathematical corrections to resolve the two active 
drugs. Furthermore, HPLC must be used which requires laborious manual sampling or 
purchase of a complicated automated instrument setup of dissolution with HPLC analysis. 
The in situ ATR-IR method has been validated by comparing dissolution profiles using UV­
Vis and HPLC methods. In addition, an accuracy of ± 2 % between IR and HPLC for the 
salicylic acid results was established. With the current configuration of the IR instrument, this 
analysis is limited by the sensitivity and wavelength range of the in situ fiber optic probe. 
However, since this chapter successfully demonstrates the versatility of this novel application 
of ATR-IR spectroscopy, it is clear that the method has excellent potential to be improved by 
modification of the IR instrument and selection of more sensitive probes. 
[60] 
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Kinetics of drug hydrolysis of common over-the-counter 
(OTC) drugs via ATR-IR spectroscopy 
This chapter focuses on describing the hydrolysis of acetylsalicylic acid (aspirin) under acidic 
conditions. The hydrolysis of aspirin was tested and monitored using ATR-IR spectroscopy. 
In the presence of an acidic medium, acetylsalicylic acid undergoes hydrolysis41 to form 
salicylic acid by the following acid-catalyzed mechanism: 
41 Choudhury, S.; Mitra, A.K. Kinetics of aspirin hydrolysis and stabilization in the presence of 2­
hydroxypropyl-B-cyclodextrin. Pharmaceutical Research 1993, 10 (1), 156-159. 
[61] 
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Background and history of Aspirin 
Aspirin is unique in its history and has many important roles in drug therapy. Aspirin is 
known to decrease pain. It fights the pain and inflammation by blocking the action of an 
enzyme called cyclooxygenase which inhibits the formation of prostaglandins.42 
Prostaglandins are chemicals that signal an injury and trigger pain. Moreover, aspirin is 
mostly known for its ability to reduce strokes. Since aspirin inhibits the formation 
prostaglandins this results in the inhibition of blood clots which could cause a heart attack or 
stroke. 
Figure 3-1 Structures of acetylsalicylic acid (aspirin) 
Aspirin 
2D 3D 

421to, Seiji; Okuda, Emiko; Minami, Toshiaki. Central and peripheral roles of prostaglandins in pain and their 
interactions with novel neuropeptides nociceptin and nocistatin. Neuroscience Research 2001, 41(4), 299-332. 
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The first synthesis of aspirin is credited to Gerhardt43 in 1853. Gerhardt was investigating 
mixed organic acid anhydrides. Felix Hoffman (1868-1946) used acetic anhydride 44 for 
aspirin's preparation. Felix Hoffmann synthesized aspirin in the laboratories of 
Farbenfabriken Bayer, Elberfeld, Germany in 1897.45 Legend has it that Hoffman wanted to 
help his sick father who was suffering from rheumatism and was no longer able to tolerate 
sodium salicylate, then widely used for his father's arthritis disease. Salicylic acid, however, 
has several bad flaws. Its bad taste, stomach irritation and other side effects spurred 
researchers to look for other derivatives. The intent was to keep salicylic's efficacy without 
the disadvantages it posed. Acetylation of the hydroxyl group was one of the logical 
modifications. This logical thinking eventually led to the synthesis and discovery of aspirin. 
Refer to Figure 3-2 below for one of the synthesis pathways that were investigated back in the 
late 1800's. 
Figure 3-2 Synthesis of aspirin-late 1800's (Chern. Draw) 
CH3COCI 

or
COOH COOH 
H3CCO", catalyst o 
+ 0 ... 
H3CCO/ 
or 
O)lCH,OH 

H2C=C=O 

43 C. Gerhardt, Annalen der Chemie, 67, 149(1853) 
44 F. Hoffmann, U.S. Patent C44077 of February 27,1900. 
45 Analytical Profiles of Drug Substances, 8 Aspirin, Klaus Florey, (1979). 
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3.2 Experimental section 
3.2.1 Chemical and materials 
Acetylsalicylic acid (aspirin) reference material (batch no. 016K0131) was purchased from 
Sigma-Aldrich. This same material was used "as is" for the powdered aspirin. Salicylic acid 
reference material (batch no. 04708HE) was purchased from Sigma-Aldrich. Acetylsalicylic 
acid 325 mg tablets (Bayer batch no. 219050N) were purchased from a local pharmacy. 
Methanol, acetone and acetonitrile (HPLC grades) were purchased from Pharmaco-Aaper. 
Sodium chloride crystals (batch no. 139602), used to prepare the Simulated Gastric Fluid 
(SGF) reagent, was purchased from Mallinckrodt Chemicals. Cone. hydrochloric acid (batch 
no. H44032), used to prepare the SGF reagent, was purchased from J.T. Baker. All solutions 
were prepared using water treated by a Milli-Q Millipore purification system. All purified 
water aliquots have resistivity of not less than 18 MOhm-cm'l. 
[64] 
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Figure 3-3 Chemical structures studied (Chern. Draw) 
OH OH 
OH 
Acetylsalicylic acid SaUcylic Acid (aspirin) 
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3.2.2 Instrumentation 
Samples were tested using Mettler Toledo's iCI0 FT-IR system using a fiber optic probe 
equipped with a 1 mm diamond coated A TR probe. The IR system was operated by Mettler 
Toledo's iC IR version 3.0 or 4.0 software. The pH determinations were carried out using a 
Symphony pH meter (model no. SB70P). All dissolution experiments were tested in Mettler 
Toledo EasyMax 102 apparatus using iC Control 4.1 software. All analytical weight 
measurements were carried out using Mettler Toledo's DeltaRange and AG204 DeltaRange 
scale. 
3.2.3 Buffered solutions 
The Simulated Gastric Fluid ("SGF"), pH 1.2, was prepared with sodium chloride and 
aqueous hydrochloric acid in accordance with the USP.46 The detailed procedure for 
preparing this test solution is shown below 
Hydrochloric Acid Solution (0.2M): 
The volumes shown in the table are for 200 mL of buffer solution. Note: Where water is 
specified for solution or dilution of test substances in pH determinations, use carbon dioxide-
free water. 
• 	 Sodium Hydroxide (0.2 M) - Dissolve 4.0 g of sodium hydroxide in water to make 100 
mL. 
• 	 Potassium Chloride (0.2 M) - Dissolve 14.91 g of potassium chloride (KCI) in water, and 
dilute with water to 1000 mL. 
46 US Phannacopoeia & National Fonnulary- Gastric Fluid, Simulated, USP [Online], http://www.usp.org/ 
(accessed May 1,2011). 
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Table 3-1 	 Hydrochloric acid buffer preparations as per United States 
Pharmacopeia (USP) 
Composition of Standard Buffer Solutions 
Hydrochloric Acid Buffer 
Place 50 mL oftha potassium chloride solution in a 200-mL volumetric fiask, add l1e specified volume of the hydrochloric acid solution, then 

add water to volume. 

;pH 1.2 13 1.4 1 5 1.6 17 1.8 19 20 21 22 

02MHCI,mL 85.0 672 53.2 41.4 32.4 260 20.4 16.2 13.0 10.2 78 

3.2.4 Hydrolysis Experiments 
HYDROLYSIS USING ASPIRIN TABLETS: 
Aspirin tablets: 325 mg acetylsalicylic acid tablets were tested in pH 1.2 simulated gastric 
fluid solutions. Dissolutions were conducted using vessel volumes of 100 mL and at 37 0e. 
All dissolutions were conducted using an agitation speed of 100 rpm. The dissolution run 
times were set for 1.5 hours. 
HYDROLYSIS USING ASPIRIN POWDER: 
Aspirin powder: acetylsalicylic acid powder samples were tested in pH 1.2 simulated gastric 
fluid solutions. Dissolutions were conducted using vessel volumes of 100 mL and at 37 <:IC. 
All dissolutions were conducted using an agitation speed of 100 rpm. The dissolution run 
times were set for 1.5 hours. 
3.2.5 ATR·IR analysis 
The ReactIRTM iC I 0 FTIR instrument is composed of an MCT detector (liquid nitrogen 
cooled) and the FiberConduit™. The FiberConduit™ is comprised of flexible IR transparent 
silver chloride/silver bromide optical fibers. The fiber optic probe interface (AgX 9.5 mm x 
1.5 m Fiber (Silver Halide)) contains a diamond tip-DiComp ATR crystal. The resolution was 
[67] 
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set to 8 wavenumbers. The optical range used by the system is: 1900 cm- I to 650 cm- I . The 
gain adjustment was set to normal (1 x) and the apodization method was set to Happ-Genzel.47 
The system uses compressed air (house air, filtered and dehumified) to purge the optics. 
HYDROLYSIS USING ASPIRIN TABLETS: 
For the hydrolysis of aspirin tablet experiments, data treatment was carried out using the 
following methodology: The data were first subjected to baseline correction. An absorption 
band at 1202 cm- l (1202-1198 cm- I ) was selected for acetylsalicylic acid. The peak area was 
calculated using a two-point baseline correction set at 1180 cm- l and 1203 cm- I . The ATR-IR 
system was configured to collect spectra every two minutes. 
For this experiment, data processing is critical to obtain well-resolved spectra. Here is how 
the data is processed. First, the peak of interest was identified (1202 cm- I ) and the area was 
calculated using a two-point baseline correction. Next, a trend analysis was performed using 
the iCIR software on this peak. This provided a plot of absorbance vs. time. This plot was 
subjected to smoothing using a 25 point smoothing parameter. After smoothing, and while 
still in the trend analysis, the baseline correct routine was performed. Then, the data were 
exported to Excel. Further data processing in Excel involved the subtraction of solvent spectra 
from reaction spectra. To perform this, a 30 min set of spectra at the beginning of the 
experiment, before aspirin pill was added, was selected. These spectra were subtracted from 
the spectra taken after the pill was dropped to give the final set of data. Within the final set of 
data, the area of the 1202 cm- I peak was calculated at each time point. Then plot of area vs. 
47 Application Note: Effect of resolution to vapor phase spectrum ofHCI in the Infrared Spectroscopy, 
Shimadzu Co., http://www2.shimadzu.com/applications/ftir/Appl FTIR HCI-vapor-phase 060 en.pdf, 
accessed 25 May 2011. 
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time were performed to give rate information. In addition, using a calibration curve, peak 
areas were converted to concentration to provide concentration vs. time plots. 
An absorption band at 1086 cm-! (1080-1090 cm-!) was selected for salicylic acid. The peak 
area was calculated using a two-point baseline correction set at 1078 cm-! and 1101 cm-!. The 
ATR-IR system was configured to collect spectra every two minutes. 
Preparation of salicylic acid standards: 325 mg of standard salicylic acid was added to a 100 
mL volumetric flask and 50 mL of SGF solution was added and the flask was sonicated for 1 
min to ensure all solids were dissolved. Finally, the solution was diluted to 100 mL using 
SGF. 
Preparation of acetylsalicyclic acid standards (in this case, there are competing concerns 
about the lower solubility of the compound and the need to limit the amount of hydrolysis of 
the compound): To decrease time, the IR was set-up and background spectra were taken prior 
to preparing the standard solution. Acetylsalicyclic acid (325 mg) was added to a 100 mL 
volumetric followed by 75 mL of SGF. The flask was sonicated for 10 - 15 to effect complete 
dissolution of the solids, diluted to 100 mL with SGF. 
HYDROLYSIS USING ASPIRIN POWDER: 
For the hydrolysis of aspirin powder experiments, data treatment was carried out using the 
procedure described above. An absorption band at 1202 cm-! (1202-1198 cm-!) was selected 
for acetylsalicylic acid. The peak area was calculated using a two-point baseline correction 
set at 1180 cm-! and 1203 cm-!. The ATR-IR system was configured to collect spectra every 
two minutes. 
[69] 
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An absorption band at 1086 cm- I (1080-1090 cm- I ) was selected for salicylic acid. The peak 
area was calculated using a two-point baseline correction set at 1078 cm- I and 1101 cm- I . The 
ATR-IR system was configured to collect spectra every two minutes. 
For all ATR-IR experiments, 256 scans were collected and co-added for each spectral point. 
On average, every spectral point, took about two-minutes to complete. For all testing, the 
calculated peak response was subjected to mathematical smoothing using the ielO software. 
The data were compared to reference standards measurements collected prior to start of the 
linearity and dissolution experiments. 
Preparation of salicylic acid standards: 325 mg of standard salicylic acid was added to a 100 
mL volumetric flask and 50 mL of SGF solution was added and the flask was sonicated for I 
min to ensure all solids were dissolved. Finally, the solution was diluted to 100 mL using 
SGF. 
Preparation of acetylsalicyclic acid standards (in this case, there are competing concerns 
about the lower solubility of the compound and the need to limit the amount of hydrolysis of 
the compound): To decrease the preparation time, the IR was set-up and background spectra 
were taken prior to preparing the standard solution. Acetylsalicyclic acid (325 mg) was added 
to a 100 mL volumetric followed by 75 mL of SGF. The flask was sonicated for 10 - 15 to 
effect complete dissolution of the solids, diluted to 100 mL with SGF. 
All dissolution experiments were allowed to equilibrate in the buffer for at least half an hour 
prior to the start of a dissolution experiment. Dissolution data were collected and plots of 
percent (%) dissolved vs. time were made. 
[70] 
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3.3 Results and discussion 
3.3.1 Hydrolysis of aspirin to salicylic acid in test tubes 
Prior to starting the hydrolysis experiments, a qualitative measurement was investigated for 
determining the presence of salicylic acid in solution. As discussed earlier, acetylsalicylic acid 
hydrolyzes to salicylic acid in the presence of an acidic medium. Ferric chloride was found to 
be a good qualitative test for salicylic acid. Ferric chloride, or iron (III) chloride, will not react 
with aspirin. It will, however, react with salicylic acid, which is used to synthesize aspirin and 
is also the hydrolysis product of aspirin. Moreover, the formation of an iron-phenol complex 
will occur.48 Thus, adding an aqueous ferric chloride solution to a sample of aspirin is a good 
way to see if there is any salicylic acid present and a purple color is an indication of salicylic 
acid. A sample of pure aspirin should not exhibit any color change. The ferric chloride color 
test is shown in Figure 3-4. 
48 Cha, K.; Park, K. Determination of iron (III) with salicy lic acid by fluorescence quenching method. Talanta 
1998,46(6),1567-1571. 
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Figure 3-4 Ferric chloride color test- control samples 
Acetyl- , ... Fe (III ; 
Conto! pH aaUcytiC SalICyliC ChIonde 
Prior to addition 
Acidof 1" Fe (III) 6A .. a.IotIde SoIudon 
AcetylsalICylIC ,/IIe1d 
1OmlnU1eS 
CHJCOOH 
Time 68 • 
SalICyliC ,IIIcId 
2 minutes Formation of an iron-phenol 
complex "ith Fe(III) gins a 
definite purple color 
1.2 SOF Acid ,/IIe1Cl SOtuUon 
! 
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Table 3-2 Ferric chloride color test concentrations 
Experiment number Weight of Aspirin (mg) Weight of Salicylic:: Acid (mg) 
1 32.1 33.4 
2 33.9 33.7 
3 31.7 35.1 
Average weight (mg) 32.6 34.1 
Volume offlask(s) (ml) 10.0 10.0 
Average Concentration (mg/ml) 3.3 3.4 I 
Table 3-3 Ferric chloride color test observations [added 2mg Iml Fe (III) 
solution] 
Acetylsalicylic acid 
Time (min) CONTROL Sample (SGF) Sample Salicylic Acid Sample 
r 
omin 
1 min 
Clear (~o color change) 
Clear (no color change) 
Clear (no color change) 
Clear (no color change) 
Dark purple 
Dark purple 
2 min Clear (no color change) Light purple Dark purple 
5min 
L--------..... 
Clear (no color change) Dar~ purple D(3rk purple 
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3.3.2 	 Hydrolysis of aspirin to salicylic acid using aspirin tablet as the 
starting ingredient 
The hydrolysis of acetylsalicylic acid (aspirin) tablets was carried out in pH 1.2 SGF 
solutions. The solutions were preheated to body temperature, 37°C, and the ATR-IR fiber 
optic probe collected baseline spectra (blank medium) for the first 30 minutes. A single 325 
mg Bayer aspirin tablet was dropped into the vessel containing 100 mL of pH 1.2 solution. 
Standard spectra of pure acetylsalicylic acid (aspirin) and salicylic acid were collected prior to 
running the dissolutions. These standards were used to identify the unique peaks of interests 
for these active drugs and for calculating absorbance intensities to concentration. As shown in 
IFigure 3-5, aspirin has a unique band at ] 202 cm- I while salicylic acid has one at 1086 cm- . 
Dissolution plots for aspirin and salicylic acid hydrosylate were made. Refer to Figure 3-6 
which plots the concentration of acetylsalicylic acid vs. time and salicylic acid hydrosylate vs. 
time. This plot shows the formation and elimination of acetylsalicylic acid. Moreover, the 
acetylsalicylic acid hydrolyzed completely to form salicylic acid as shown in the plot. The 
presence of salicylic acid is detected by the IR system and plotted on a secondary axis as 
shown in Figure 3-6. In addition, the ferric chloride color test was used to visually inspect the 
presence or absence of salicylic acid. The ferric chloride solution was added to the aspirin 
tablet dissolution vessel after sixty minutes. The solution within the vessel quickly turned to a 
purple color as shown in Figure 3-7. 
[741 
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Figure 3-5 Waterfall plot of aspirin tablet dissolution 
This is a waterfall plot for the dissolution of 325 mg aspirin tablet in SGF. As seen in the 
figure, there are two peaks of interest; one at ~1086 cm-1 and one at ~1205 em-I. These 
represent salicylic acid and aspirin respectively. The purple color in the figure represents 
higher intensities while the blue green represent lower intensities or concentrations. As seen 
in the figure aspirin increases with time and then disappears while salicylic acid increases 
with time. 
1086 

(Salicylk: Acid, 

1205 
[Acetylsalicylic Acid (Aspirin)] 
Wavenumber lem-1' 
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Figure 3-6 Hydrolysis of Aspirin Tablets (325 mg) in pH 1.2 SGF Solution (n=2) 
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Figure 3-7 Ferric chloride color test for salicylic acid (tablet dissolution) 
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3.3.3 	 Hydrolysis of aspirin to salicylic acid using aspirin powder as the 
starting ingredient 
It was equally important to understand the rate of hydrolysis of aspirin in powder form. Since 
the hydrolysis of aspirin in a tablet depends on the dissolution of aspirin into solution first, the 
rate of hydrolysis of pure aspirin powder should be relatively quicker because all particles are 
immediate exposed to the dissolving medium. In fact, the rate limiting step in this case would 
be the dissolution of the particles into the acidic medium. As a result, the hydrolysis of aspirin 
to salicylic acid was monitored and measured using pure aspirin powder. Known amounts, 
equivalent to the amount found in a tablet, were placed in the dissolution vessels containing 
an acid solution (PH 1.2 SOF) and the dissolution profiles were collected using A TR-IR 
spectroscopy. Figure 3-8 shows the dissolution profiles of aspirin and salicylic acid using 
aspirin powder. In addition, the figure clearly shows the formation and then elimination of 
acetylsalicylic acid in solution (black line) and the simultaneous formation of salicylic acid 
hydrosylate in solution (red line). 
[77] 
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Figure 3-8 	 Hydrolysis of acetylsalicylic acid powder to salicylic acid hydrosylate 
in pH 1.2 solution 
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3.3.4 Hydrolysis data: comparison between tablet and powder formulations 
Figure 3-9, compares the IR dissolution profiles of the salicylic acid component in powder 
and tablet form. As expected the rate of dissolution and hence hydrolysis of salicylic acid, is 
faster in the powder form. The tablet formulation has to undergo wetting, disintegration and 
deaggregation which take time. Similarly, Figure 3-10, compares the IR dissolution profiles of 
the aspirin component in powder and tablet form. As expected the rate of dissolution of 
aspirin, is faster in the powder form. For the tablets, in each case, there is an initial 
mechanical lag associate with the physical breakdown of the tablet. However, in the case of 
the experiments with the powders, there no mechanical lag and dissolution occurs 
immediately. However, with powdered acetylsalicylic acid, there is an interesting bimodal 
behavior. Initially, an immediate fast dissolution is observed and a secondary process is also 
observed at a slower rate as the dissolution occurs. Refer to Figure 3-8. The initial rapid 
dissolution likely occurs from particles that are well wetted in the initial exposure to the 
dissolution medium. However, aggregation of the powder was also observed suggesting that 
some of the acetylsalicylic acid particles were not wetted. The dissolution of these aggregates 
is associated with the slower dissolution process. In addition, the aspirin powder was used "as 
is" from the reagent container, therefore, the powder was inhomogeneous consisting of differ 
particle sizes with small and large crystal. It is likely that the larger particles and crystals 
contribute to the secondary dissolution process. However, that this process is not observed 
with salicylic acid (see Figure 3-9) is reasonable, first, because salicylic acid is more 
hydrophilic than acetylsalicylic acid, and, second, because salicylic acid dissolves at a faster 
rate, leaving less time for aggregation to occur. 
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To develop an overall understanding of the dissolutionlhydrolysis processes that occur with 
aspirin, a composite plot was prepared (Figure 3-11). In this plot, the dissolutions of aspirin 
powder and tablet and the hydrolysis of aspirin powder and tablet to form the salicylic acid 
hydrosylate are shown. The solid blue-line (aspirin powder) and the dotted red-line (aspirin 
tablet) compare the IR dissolution profiles of the aspirin component in powder and tablet form 
respectively. As expected, the rate of dissolution of aspirin is faster in the powder form. For 
the tablets, in each case, there is an initial mechanical lag associate with the physical 
breakdown of the tablet. However, in the case of the experiments with the powders, there no 
mechanical lag and dissolution occurs immediately. This plot also compares the release 
profiles of the salicylic acid hydrosylate in tablet (dotted green-line) and powder formulation 
(solid black line). Again, for the tablet, there is an initial mechanical lag associated with the 
physical breakdown of the tablet. Also, the hydrolysis of aspirin in the powder formulation 
appears to be quite rapid. Moreover, the plot shows this phenomenon occurring prior to the 
dissolution of the powder aspirin. Currently, the dissolution profiles were run at 100 rpm with 
a collection rate of two-minutes. A higher agitation speed and faster acquisition time (i.e. 
every 1 minute) should synchronize the dissolution of the aspirin and then the release of the 
salicylic acid hydrosylate in the powder formulation. 
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Figure 3-9 Release profile of Salicylic Acid ("SA") during hydrolysis in SGF 
(pH1.2): powder vs. tablet 
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Figure 3-10 Release profile of acetylsalicylic acid (aspirin) during hydrolysis: 
powder vs. tablet 
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Figure 3-11 Release profile of acetylsalicylic acid (aspirin) and salicylic acid 
hydrosylate during hydrolysis: powder vs. tablet 
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3.3.5 Kinetic rates observed during hydrolysis experimentation 
The kinetic rates were also determined for the experiments discussed earlier. The rates were 
determined using the slopes of the dissolution plots. The rates were compared to literature 
research49 and were found to be equivalent within experimental error. In fact, the literature 
data shows the rate of hydrolysis of aspirin under acid medium varies from 0.91 min-! to 1.74 
min- I depending on the pH and temperature of the solution. Refer to Table 3-4 for details. 
According to Habib and co-workers the hydrolysis rate of aspirin was found to be 0.91 min-! 
at pH 1.0 and 30°C. Choudhury and co-workers reported the hydrolysis rate as 1.74 min-I at 
pH 1.3 and 40°C. If both literature studies are taken into account and a linear plot is 
constructed with rate vs. pH/temp, the expected rate of hydrolysis at conditions similar to this 
research should be 1.46 min-I. Furthermore, in this study, the hydrolysis of aspirin to salicylic 
acid, using aTC aspirin tablets in pH 1.2 SGF and at 37°C, was found to be 1.03 min-I. The 
hydrolysis of aspirin powder to salicylic acid was found to be 1.23 min-I. 
49 a) Habib, M.1.; Rogers, I.A. Kinetics of hydrolysis and stabilization of acetylsalicylic acid in liposome 
formulations. International Journal a/Pharmaceutics 1998,44, 235-241.b) Choudhury, S.; Mitra, A.K. Kinetics 
of aspirin hydrolysis and stabilization in the presence of 2-hydroxypropyl-B-cyclodextrin. Pharmaceutical 
Research 1993,10 (1),156-159. 
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Table 3-4 Kinetic rates for hydrolysis of aspirin in acidic medium 
Description Kinetics Rate (lImin·1 ) 
(acetylsalicylic acid= 7.5 mM) Ref At pH 1.0 and 30 QC -­
Rate of Hydrolys is 0.91 
At pH 1.3 and 40 QC (acetylsalicylic 
Rate of Hydrolysis 
I At pH 1.2 and 37°C (acetylsalicylic acid= 18 mM) (this 
work) 
I Rate of Dissolution (Tablet) 1 
Rate of Hydrolysis (Tablet) 
Rate of Dissolution (Powder) 
1.03 
1.59 
I 
! 
Rate of Hydrolysis (Powder) 1.23 
The rates of the reactions were determined from the dissolution plots. Refer to Figure 3-\ O. In 
order to calculate the rates using the plot, the following procedure was implemented. First, a 
plot of % dissolved vs. time is obtained. Next, a straight line is drawn over the area of the 
dissolution curve where dissolution starts to occur (middle area in this case). Furthermore, the 
slope of the curve is obtained and from this the rate of hydrolysis is reported. Refer to Figure 
3-12 and Figure 3-13. 
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Figure 3-12 Typical calculation plot of rate from dissolution 
Below is a schematic diagram illustrating how to calculate the rate. 
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3.4 Chapter summary 
In this chapter, it was demonstrated that in-situ infrared spectroscopy is a viable technique for 
detecting and measuring the hydrolysis of acetylsalicylic acid (aspirin) in acidic media. The 
IR system was found to be impressive in its capability of measuring very low concentrations 
and was able to distinguish separate components of a mUltiple component hydrolysis system 
without requiring manual sampling. This versatility is demonstrated by observing the 
simultaneous dissolution and then conversion of the acetylsalicylic acid API to salicylic acid. 
In the tablet formulation, the rate of dissolution was found to be 1.62 min- l based on the initial 
slope of the dissolution profile. Moreover, the hydrolysis rate was found to be 1.03 min-I 
based on the salicylic acid formation and dissolution profiles. In the powder formulation, the 
rate of dissolution was 1.59 min-I. The rate of hydrolysis was found to be 1.23 min-I. As 
expected, this rate is slightly higher since tablets require an initial period of disintegration and 
deaggregation. Moreover, the rate of hydrolysis of the powder formulation is closer to 
Choudhury's finding. In the tablet experiment, the rate of hydrolysis of aspirin does not 
exactly match the rate of hydrolysis from the powder experiment. This could be explained by 
several reasons. First, there is competing dissolution within the vessel. The tablet has to 
undergo disintegration and dissolution prior to hydrolysis occurring. Second, the stirring rate 
was too slow. In the powder formulation, by the time the active drugs reaches the fiber optic 
probe, the hydrolysis has already begun. This is especially important in the powder form 
where there is not competing dissolution of tablet. Refer to Figure 3-9. The salicylic acid 
hydrosylate was observed before the acetylsalicylic acid from the powder. Third, the IR 
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system was allowed to collect spectra every two minutes. This should be enhanced to collect 
every one minute in order to detect the hydrolysis quicker. 
This research was possible because of the versatility of ATR-IR system. Specifically, the 
unique fingerprint region of the lR spectra gave detailed information about the release profile 
of the drug. Conventional methods, namely, in-situ UV-Vis, would only show the release 
profile of one component. However, peak deconvolution software can be used to analyze 
aspirin hydrolysis. Moreover, the hydrolysis and transformation of the drug from one form to 
another may be missed with conventional techniques. ATR-IR captures those minor details 
and displays them in the fingerprint region, as shown earlier in the results. The unique feature 
of this system is that it is able to detect several forms of the same drug. In other words, it was 
able to detect the formation and elimination of a pharmaceutical drug (aspirin) while detecting 
the formation of the hydrosylate of the aspirin (salicylic acid) in real-time. In addition, this 
system could be used to study other potential transformations. One example might be the 
dimerization of acetaminophen as mentioned earlier. The novelty with this particular system 
is its capability to see drug transformations in solutions while conducting the experiment in­
situ. Since this chapter successfully demonstrates the versatility of this novel application of 
ATR-IR spectroscopy, indicating that that the method has excellent potential for detailed 
studies of the dissolution and hydrolysis kinetics of pro-drug formulations and drugs which 
hydrolyze under acidic conditions simulating stomach conditions. 
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4 	 Instrument Development Proposal: "Solv-IR" as an In-Situ 
ATR-IR Instrument for Solvation Chemistry 
This chapter focuses on describing the design and potential application of the "Solv-IR" 
system. The Solv-IR system is a new system that combines dissolution technology with 
attenuated total reflectance-infrared spectroscopy (ATR-IR). A Major Research 
Instrumentation (MRI) grant was recently submitted with the National Science Foundation for 
funding of this project. The details, described below, give an overview of the new system as 
well describe the specific components of the proposed new system. 
4.1 	 Background 
Solvation, also sometimes called dissolution, is the process of attraction and association of 
molecules of a solvent with molecules or ions of a solute. As ions dissolve in a solvent they 
spread out and become surrounded by solvent molecules. By an IUPAC definition, solvation 
is an interaction ofa solute with the solvent, which leads to stabilization of the solute species 
in the solution. 50 Solvation is also a kinetic process with a thermodynamic conclusion.5 ! Most 
instrumentation used to investigate solvation focuses on the thermodynamic conclusion, i.e., 
the structure and concentration of the solvated species at equilibrium. Dynamic study of 
solvation either requires manual sampling or in situ UV-Vis detection which (in spite of 
excellent curve fitting software) has limited capability for multi-component analysis and for 
species that chemically transform. The goal is to construct a new instrument that allows 
50 IUPAC, Compendium ofChemical Tenninology, 2nd ed. (the "Gold Book") (1997). Online corrected version: 

(2006-) "solvation". 

51 Anslyn, E. V.; Dougherty, D. A. Chapter 3: Solutions and Non-Covalent Binding Forces. Modern Physical 

Organic Chemistry; University Science, California, 2006. 
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dynamic measurement of solvation of a chemical substance or chemical mixture with in situ 
infrared detection. Because of the large number of vibration modes available for many 
molecules, infrared spectroscopy is much more selective than UV -Vis. In addition, 
characteristics of the IR band can provide information about the mechanism of dissolution 
including hydrogen bonding interactions and aggregation of solute molecules.52 As discussed 
earlier, infrared spectroscopy using attenuated total reflectance (A TR) probes is quantitative, 
thus, providing precise measurement of solute concentrations. The proposed name for the 
instrument is Solv-IR which indicates that it uses infrared technology for investigation of 
solution chemistry. The target instrument will have several attractive features: a) 10-6 M 
sensitivity, b) chemically robust; c) conventional IR spectral range; d) precise control of 
reaction vessel temperature; f) integrated stirring controls; g) n=6 solvation vessels to provide 
appropriate statistics; f) software for instrument control, data acquisition and processing. The 
Solv-IR will prove to be useful in the following scientific applications: 
• 	 Solvation of single component species such as homogeneous catalysts53 and substances 
with different crystalline morphologies. 54 
• 	 Crystallization studies (the reverse of solvation!).55 
52 The Chemical Physics of Solvation, Part B, Spectroscopy of Solvation, R. R. Dogonadze, E. Kalman, A. A. 

Kornyshev, J. TJlstrup, Eds., Elsevier, The Netherlands, 1986. See: Chapter I: "Spectroscopic approaches to the 

study of ionic solvation," G. Kabisch, E. Kalman; Chapter 2: "Interactions in and structures of ionic solutions 

and polyelectrolytes, Infrared Results," G. Zundel, J. Fritsch; Chapter 3: "Infrared Spectrscopic results on 

solvate structures in crystals," G. Zundel, J. Fritsch. 

53 Studies of catalyst dissolution, a) Sun, Y.K.; Le Blond, C. R.; Wang, J.; Blackmond, D. G.; Laquidara, J.; 

Sowa, J. R. Observation of a [RuCI2«(S )-( -)-tol-binap )]2aN(C2H5)3-Catalyzed Isomerization-Hydrogenation 

Network, Journal American Chemical Society 1995, 117, 12647. b) Shaw, J.; Chen, Y.S.; Fulton, J.; Linehan, J.; 

Gutowska, A.; Bitterwolf, T. Structural evolution of a recoverable rhodium hydrogenation catalyst. Journal of 

Organometallic Chemistry 2008, 693, 2111-2118. 

54 a) Acquah, c.; Karunanithi, A. T.; Cagnetta, M.; Achenie, S. L. Linear models for prediction of ibuprofen 

crystal morphology based on hydrogen bonding propensities. Sub Fluid Phase Equilibria 2009, 277(1), 73-80. 
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• 	 Studies of chemical and mechanical parameters that effect solvation including 
temperature, agitation, solvent-type, pH, shape and hardness of the solid.56 
• *Studies of tablet formulations including chemical effects of co-ingredients.57 
• *Monitoring of multi-component and controlled release formulations.58 
• *Solvation rates for components that chemically transform on the solvation time scale.59 
• 	 *Environmental chemistry for study of dispersants (emulsifier, surfactants) for treating 
chemical (e.g., petroleum) spills and other anthropomorphic events.60 
• 	 Kinetics of micelle formation.61 
The above examples represent key applications of IR spectroscopy in the chemistry of 
solution; however, there are many more examples.62 Preliminary results have been obtained 
b) Chieng, N; Rades, T.; Aaltonen, J. An overview of recent studies on the analysis of pharmaceutical 

polymorphs. Journal ofPharmaceutical and Biomedical Analysis, In Press (2011). 

55 Halasz, I.; Biljan, I.; Novak, P.; Mestrovic, E. ; Plavec, 1.; Mali, G.; Smrecki, V.; Vancik, H. Cross­

dimerization of nitrosobenzenes in solution and in solid state. Journal ofMolecular Structure 2009, 918( 1-3). 

56 Vitha, M.; Carr, P. W. The chemical interpretation and practice of linear solvation energy relationships in 

chromatography. Journal ofChromatography A 2006, 1126( 1-2), 143-194. 

57 a) Van der Weerd, 1.; Chan, K. L. A.; Kazarian, S. G. An innovative design of compaction cell for in situ FT­

lR imaging of tablet dissolution. Vibrational Spectroscopy 2004,35(1-2),9-13. b) Chan, K.L.A.; Elkhider, N.; 

Kazarian, S.G. Spectroscopic Imaging of Compacted Pharmaceutical Tablets. Chemical Engineering Research 

and Design 2005,83(11), 1303-1310. c) Dressman, J. J.; Kramer, 1. K., Eds. Pharmaceutical Dissolution 

Testing; Taylor and Francis: Florida, 2005. d) Hanson, R; Gray, V. Handbook of Dissolution Testing, 3rd ed., 

Dissolution Technologies: Delaware, 2004. 

58 Van der Weerd, J.; Kazarian, S.G.; Combined approach ofFTIR imaging and conventional dissolution tests 

applied to drug release. Controlled Release 2004, 98,295-305. 

59 Kokot, . Burda, K. Simultaneous determination ofsalicyJic acid and acetylsalicylic acid in aspirin delayed­

release tablet formulations by second-derivative UV spectrophotometry. Journal ofPharmaceutical and 

Biomedical Analysis 1998, 18,871-875. 

60 a) Fingas, M. Oil Spill Dispersants: A Technical Summary. Oil Spill Science and Technology 2011,435-582. 

b) Brandvik, J; Daling, S. Optimising oil spill dispersants as a function ofoil type and weathering degree: a 

multivariate approach using partial least squares (PLS). Chemometrics and Intelligent Laboratory Systems 1998, 

42(1-2),73-91. c) Regan, F.; Meaney, M.; Vos, J.G.; Maccraith, B.D.; Walsh, lE. Determination of Pesticides 

in water using ATR-FTIR spectroscopy on PVC/chloroparaffin coatings. Analytical Chimica Acta 1996, 334, 

85-92. 

61 Ceraulo, L.; Dormond, E.; Mele, A.; Turco Liveri, V. FT-IR and nuclear overhauser enhancement study ofthe 

state of urea confined in AOT-reversed micelles. Colloids and Surfaces A: Physicochemical and Engineering 

Aspects 2003, 218(1-3),255-264. 
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for the above examples with an asterisk (*) using a single probe/vessel prototype.63 However, 
all of the above examples are important to chemists and the Solv-IR instrument will provide 
fundamental and practical insight into these processes. 
4.2 Broader impacts from the proposed activities 
The activities described in this project have several characteristics that are likely to have a 
broad impact on our nation's scientific infrastructure and perhaps provide economic 
opportunities. Thus, the broader impacts from the proposed activities are described here. 
• 	 First, there is substantial evidence that the proposed Solv-IR will be commercially viable. 
Investigation of solvation chemistry of single compounds or mixtures ensures that 
compounds are accurately delivered or dispersed at desired concentration and time. In the 
US alone there are at least nine companies that sell solvation units (basic: Hanson, Varian, 
Sotax, Logan, Distek; robotic: Zymark; UV-Vis monitoring: Pion, C-Technologies, Leap 
Technologies) and retail prices range from $20 K for basic units, $100 K for UV-Vis 
equipped units and $250 K for robotically controlled units. The total market capital of this 
industry is estimated to be $500 M USD. 
• 	 Second, the Solv-IR is a potential driver to a field of research that is hungry for more 
information about the chemistry that is occurring inside the reaction vessel. 
621. Workman Jr. Review of Near-Infrared and Infrared Spectroscopy. The Handbook ofOrganic Compounds; 

Academic Press: California, 2001; pp 79-129. 

63 Kassis, A.; Bhawtankar, V.M.; Sowa, l.R. Attenuated total reflection infrared spectroscopy (ATR-IR) as an in 

situ technique for dissolution studies. Journal ofPharmaceutical and Biomedical Analysis 2010,53,269-273. 
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4.3 Limit of detection (LaD) and limit of quantitation (LOQ) data 
Before the instrument design is discussed, an overview of limit of detection (LOD) and limit 
of quantitation (LOQ) will be made.64 The LOD and LOQ levels were calculated for the 
existing ATR-IR system coupled with different types of fiber optic probes. Three types of 
fiber optic probes were tested: DiComp probe, Flow-Cell probe and K4 probe. 65 Differences 
between these probes will be discussed below. 
As per the IUPAC, The limit of detection, expressed as a concentration or quantity, is derived 
from the smallest measure that can be detected with reasonable certainty for a given analytical 
procedure. The limit of detection is the lowest concentration of an analyte that the analytical 
process can reliably detect.66 The LOD level is calculated from the average of the blank, 
standard deviation of the blank and a confidence factor.67 The limit of quantification refers to 
the smallest concentration or the mass which can be quantitatively analyzed with reasonable 
reliability by a given procedure. There are several techniques available to calculate detection 
limits. The limit of detection is estimated as three times the standard deviation of the blank 
and the limit of quantitation is estimated as ten times the standard deviation of the blank. Of 
the three fiber optic probes mentioned earlier, the DiComp probe is the most useful to 
dissolution chemistry. The DiComp probe is diamond coated to protect the Zn-Se ATR crystal 
from attack by acidic medium. Since a lot of the dissolutions are carried out in acidic medium 
(pH 1-3), the A TR crystal needs the extra coating to ensure longevity of the probe. Based on 
64 Venkatasami, G.; Sowa, lR. A Rapid, Acetonitrile-Free, HPLC Method for Determination of Melamine in 

Infant Formula. Analytica Chimica Acta 2010,665,227-230. 

65 Fiber optic probe specification obtained from: http://us.mt.com/us/en/home.html# (accessed May 1, 2011). 

66 IUPAC, Compendium of Chemical Terminology, 2nd ed. (the "Gold Book") (1997) 

67 MacDougall, D.C.; Warren B. Guidelines for Data Acquisition and Data Quality Evaluation in Environmental 

Chemistry. Analytical Chemistry 1980, 52,2242-49. 
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the research it was detennined that the LOD and LOQ levels for the DiComp probe were 
found to be 1.7x 10-4 M and 5.7 x 10-4 M, respectively. This implies that the LOD level is 
0.02 mg/ml. Refer to Figure 4-l. Thus, the optics of the ATR-IR system will need to be 
enhanced in future research in order to achieve a lower limit of detection level. The goal is to 
increase the sensitivity so that the system is able to detect one mg of an active drug in a 500 
ml vessel volume or 0.002 mg/ml. The ratio of placebo to active will play an important role in 
the sensitivity and will need to be considered during the analysis. 
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Figure 4-1 Limit of detection of ATR-IR system 
Salicylic LOD_linearity for Salicylic Acid (Concentration vs. Absorbance Band Intensity): 
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Figure 4-2 Fiber optic probes specifications (ref 65) 
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Figure 4-3 Calculated LOD and LOQ values 
Description LOO and LOQ Results for iC10 IR System Probes 
IR Probe K4 Probe Oi Comp Probe Flow Cell 
SIN 2 13 23 
LOO (mM) 0.63 mM 0.17 mM 0.10 mM 
LOQ (mM) 2.11 mM 0.57 mM 0.33 mM 
Probe Picture 
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Figure 4-4 LOD/LOQ Sample Calculation Sheet- DiComp Probe Results-1 
Wavenumber (cm-1) Replicate 1 Replicate 2 Replicate 3 Replicate 4 Replicate 5 Replicate 6 Replicate 7 Replicate 8 
1395.6576 0.200564 0.200921 0.200813 0.201180 0.200994 0.201616 0.200948 0.201662 
1391.9259 0.199833 0.200161 0.200107 0.200800 0.200230 0.200833 0.200502 0.201184 
138&.1942 0.200339 0.200243 0.200627 0.200778 0.200673 0.201268 0.201548 0.201443 
1384.4625­ 0.201886 0.201437 0.202093 0.201718 0.201690 0.202646 0.202697 0.202794 
1380.7308 0.201399 0.201482 0.201690 0.201366 0.201696 0.202087 0.201709 0.201777 
1376.9991 0.200419 0.201039 0.200280 O~ 0.200860 0.200998 0.201240 0.200636 
1373.2674 0.199646 0.200064 0.199234 0.199986 0.200016 0.199902 0.200461 0.200062 
1369.5357 0.198177 0.199447 0.199049 0.199630 0.199701 0.198879 0.199716 0.199766 
AREA CALCULATION 
Wavenumber (cm-1) Replicate 1 Replicate 2 Replicate 3 Replicate 4 Rep~cate 5 Replicate 6 Replicate 7 Replicate 8 
1395.6576 0.7472 0.7483 0.7481 0.7500 0.7486 0.7509 0.7490 0.7516 
1391.9259 0.7468 0.7471 0.7475 0.7493 0.7478 0.7503 0.7502 0.75012 
1388.1942 0.750S 0.7495 0.7512 0.7510 0.7504 0.7535 0.7543 0.7542 
1384.4625 0.7525 0.7518 0.7534 0.7E·21 0.7523 0.7550 0.7!:-46 0.7!:-49 
1380.7308 0.7497 0.7510 0.7500 0.7497 0.7E·09 0.7521 0.7518 0.7!:-07 
1376.9991 0.7463 0.7484 0.7454 0.7472 0.7480 0.7480 0.7495 07474 
1373.2674 0.7432 0.7454 0.7431 0.7454 0.7458 0.7441 0.7467 0.7460 
AREA 5·.2361 5·.2415 5.2388 5.2447 5.2438 5.2!:-38 5.2561 5.25.131 
DiComp Fiber Optic Probe LOD/LOQ using Salicylic Acid 
0.2100 -Replicate 1 
-Replicate 2 
•
0.2050 -Replicate 3 
IS 
I 0.2000 
- :s...-­ -Replicate 4 
-ReplicateS
-
-Replicate 6 
0.1950 
-Replicate 7 
1365 1370 1375 1380 1385 1390 1395 1400 Replicate 8 
Wavenumber (em-l) 
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Table 4-1 LOD/Loa Sample Calculation Sheet- DiComp Probe Result-2 
Title' LOD/LOQ Calculations 
Row Number Column A Column B 
1 Analyte Salicylic Acid 
2 Method LOD/LOQ 
3 Date Nov. 27. 2010 
4 Instrument TiC10 Di Comp Probe 
5 Spike 0.01594 
6 Units mglmL 
7 Replicate 1 5.23610 
8 Replicate 2 5.2415 
9 Replicate 3 5.2388 
10 Replicate 4 5.2447 
11 Replicate 5 5.2438 
12 Replicate 6 5.2538 
13 Replicate 7 5.2561 
14 Replicate 8 5.2561 
15 Mean 5.2464 
16 Std Dev 0.0079 
17 LOD i 0.02 mg/mL 
18 LOQ 0.08 mg/mL 
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Figure 4-5 LOD/LOQ Sample Calculation Sheet- Flow Cell Probe Results-1 
Wavenumber (cm-1} RepWcate 1 Replicate 2 Replicate 3 Replicate 4 Replicate = Replicate 6 Replicate 7 Replicate 8 
1257.5846 0.245674 0.245473 0.245643 0.245271 0.245642 0.245345 0.245116 0.245111 
1253.8529 0.246221 0.245960 0.246132 0.245975 0.246288 0.245932 0.245688 0.245637 
1250.1212 0.247103 0.246963 0.246949 0.246986 0.247071 0.246917 0.246626 0.246566 
1246.3894 0.247688 0.247507 0.247560 0.247482 0.247503 0.247522 0.247236 0.247133 
1242.6577 0.247831 0.247655 0.248021 0.247722 0.247698 0.247743 0.247524 0.247418 
1238.926 0.247866 0.247663 0.247965 0.247818 0.247578 0.247656 0.247371 0.247329 
1235.1943 0.247832 0.247736 0.247683 0.247606 0.247415 0.247474 0.247249 0.247160 
1231.4626 0.247600 0.247500 0.247507 0.247469 0.247191 0.247384 0.247184 0.246936 
AREA CALCULATION 
Wavenumber (cm-1) Replicate 1 Replicate 2 Replicate 3 Replicate 4 Replicate: Replicate 6 Replicate 7 Replicate 8 
1257.5846 0.9178 0.9169 0.9176 0.9166 0.9179 0.9167 0.9158 0.9157 
1253.8529 0920~ 0.9197 0.9200 0.9198 0.9205 0.9197 0.9186 0.9184 
1250.1212 0.9230 0.9226 0,9227 0.9226 0.9228 0.9226 0.9215 0.9212 
1246.3894 0,9244 0.9239 0.9247 0,9240 0.9240 0.9241 0.9231 0.9228 
1242.6577 0.9249 0.9242 0.9254 0,9242 0.9241 0.9242 0.9234 0.9231 
1238.926 0,9249 0.9243 0.9248 0.9238 0.9236 0.9237 0.9229 0.9226 
1235.1943 0.9244 0.9240 0.9240 0,9235 0.9229 0.9233 0.9225 0.9220 
AREA 6.4599 6.4558 6.4592 6.4546 6.4558 6.4542 6.4478 6.4458 
FlowCell Probe LOO/LOQ using Acetaminophen 
-Replicate 10.2500 
-Replicate 2 
-..!!BI!e._,,_ 
-- . 
-Replicate 3~ 
II! 0.2450 - -Replicate 4i 
-Replicate 5 
- Replicate 6 
1230 1235 1240 1245 1250 1255 1260 -Replicate 7 
Replicate 8 
0.2400 
Wavenumber (em·l)
! 
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4.4 Instrument design 
The proposed instrument is illustrated in Figure 4-7. It has ten overall features which are 
grouped into the following units: I) Optical Path which includes the source, fiber optic cables, 
A TR crystal, and detector, II) Six Solvation Vessels including the overhead stirrers, reaction 
vessels and temperature control, and, III) Instrumentation Control and data 
acquisition/processing software. The choice of six solvation vessels comes from a statistical 
requirement that is frequently found encountered in complicated experiments where 
agreement of n=6 experiments is considered to provide a statistically robust analysis.68 
Although chemists are frequently satisfied with one reproducible yield or agreement of three 
measurements of a rate constant, applied applications of chemistry frequently require more 
rigorous statistics. 
Some regulatory agencies require statistical agreement of six simultaneous solvation studies. 
Thus, to make the instrument more statistically rigorous and competitive with related 
instruments on the market, it is important that we use n=6 reaction vessels. Also note that a 
circular arrangement of the solvation vessels is proposed as this design is takes up less space 
relative to a linear or block arrangement. 
We will assemble our new instrument from commercially available components. Thus, our 
main role will be to select the most appropriate components, to make sure that they properly 
communicate and have reliable computer software for instrument control data acquisition and 
processing. Our target specifications are: 
68 a) Wilson, E. B. An Introduction to Scientific Research; Dover Press: New Jersey, 1991. b) Dumont, M. L.; 
Berry, M. R.; Nickerson, B. Probability of passing dissolution acceptance criteria for an immediate release 
tablet. Journal ofPharmaceutical and Biomedical Analysis 2007, 44(1), 79-84. 
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1) Sensitivity (as defined as limit of detection, where signal: noise ratio = 3: 1) < 10-6 M. 

2) Sample time < 1 min per solvation vessel. 

3) Wavelength range: 4000 - 500 cm- I . 

4) Temperature control < +/- 0.50 C and range -20 to 1000 C. 

5) Chemical stability: aqueous solvent conditions (pH 1 - 12), common organic solvents 

and tested for safe use of volatile organic solvents such as diethyl ether when used in a 
fume hood. 
6) Although this is a scientific proposal, we desire that the instrument will be marketable, 
thus, we will aim for a retail cost of $200 K. 
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Figure 4-6 Diagram of proposed Solv-IR Instrument 
A diagram of the proposed instrument is shown below. 
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4.5 System components 
4.5.1 Radiation source 
This is an encased source for IR radiation consisting of an IR element and Zn-Se lens. A 
suitable unit is available from Oriel, Apex Infrared Source, Model 66471 (7" H x 12" W x 10" 
D). 
4.5.2 Interferometer 
This is necessary to modify the source IR light to a broad range of frequencies. 
Interferometers provide for rapid acquisition and signal averaging. Potential vendors include 
BrukerOptics. However, an interesting alternative for initial investigations will be to salvage 
components from a surplus IR (we have two units in disrepair in our department with 
interferometers). 
4.5.3 Two Six-device Multiplexors 
These devices channel the light from the source so that the maximum amount of light passes 
through each vessel and then directs the absorbed light to the detector. They are sequential 
devices such that input/output light spends a defined amount of time at each vessel. 
4.5.4 Six A TR Probes 
Each probe consists of an input fiber optic cable, an A TR crystal and an output fiber optic 
cable. The cables are chalcogenide fibers that perform well in the mid-IR range and are 
sufficiently flexible so they can be arranged within the instrument and connected to the A TR 
[104] 
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crystal. Potential suppliers are also RoMack Corp. and Hellma Scientific. The A TR crystal is 
a Zn-Se crystal will provide the desired spectral window (4000 500 cm-!); however, since 
Zn-Se is sensitive to acids and easily abrased, we will identify a suitable coating. So far, the 
best choice is a diamond coated Zn-Se crystal which provides excellent chemical stability. 
The narrower spectral range 1900 - 600 cm-! is a satisfactory compromise because the 
"fingerprint" region frequently provides an excellent array of absorption bands. Pike 
Technologies provides an excellent selection of A TR and coated A TR crystals. 
4.5.5 Detector 
The goal is to obtain a single detector sensitive to 10-6 M. Currently, the most sensitive 
detectors are liquid nitrogen-cooled HgCdTe (MCT) detectors. However, if technology 
advances, we hope to incorporate a sensitive ambient temperature detector such as Peltier­
stabilized DTGS (deuterated triglycine sulfate) detector. Commercial vendors include 
BrukerOptics. 
4.5.6 Six Solvation Vessels 
Preliminary work can be performed on glass 1 L vessels that we have in stock. We will need 
to hire a glass blower (ChemGlass, Vineland, NJ) to modify each vessel with a rectangular 
fitting capable of holding rhombohedral ATR crystal as shown in Figure 4-7. 
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Figure 4-7 	 Sketch of ATR crystal embedded in the side wall of the 1 L glass 
vessel. The area directly under the stir shaft is known to have poor 
mixing and as indicated by the term "dead zone". 
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Alternatively, polyethylene and fluoropolymer vessels are available which will be easier to 
modify especially in prototypes. Quality Lab Accessories (QLA) provides an excellent 
catalog of glass and polymer vessels, caps and stir shafts. Controlled overhead stirring is 
performed by a simple gear assembly (Figure 4-8). 
Temperature control will be provided by assembling a water bath around the solvation 
vessels. However and ideal alternative is provide a thermally-conductive jacket around each 
vessel with which temperature is controlled (for example, see Distek's Evolution 6100 
Bathless apparatus.69 
69 Evolution 6100 Distek Bathless Dissolution Testing Equipment, Distek Home Page [Online], 
htlp:i/www.distekinc.comlproducts/dissolutionevolution6100.htm (accessed on January 26,2011). 
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Figure 4-8 Top plate of constant rpm stirring assembly showing motor, main gear 
and minor gears which drive the stir shafts in each vessel 
Controlled 
rpm Motor 
Minor gear 
drives stir 
shaft 
4f-----j'---- Main gear 
driven by motor 
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4.6 Instrument Controll Acquisitionl Processing. 
Software packages to perform these operations have been well-designed by a number of 
vendors we will seek an opportunity to license their software and hire a consultant to modify 
the software package. 
4.7 Anticipated technical difficulties 
1. It may be difficult to match items from different vendors. Solution: try to use one or 
two primary vendors. For example, BrukerOptics has MATRIX and TENSOR IR 
spectrophotometers which allow multiple A TR probe attachments. If either of these meet 
sensitivity requirements, then it would be best to build the Solv-IR from one of these units. A 
quote for the MATRIX-MF instrument including spectrophotometer, ATR-probes and 
software has been obtained to support this approach. 
ii. It may be difficult to achieve sensitivity within a reasonable time frame if all six 
vessels are to be measured with one spectrophotometer. Solution: assemble an apparatus with 
two or three spectrophotometers. 
111. It may be difficult to achieve sensitivity with a vessels are to be measured with one 
spectrophotometer. Solution: assemble an apparatus with two or three spectrophotometers. 
4.8 Chapter summary 
The preliminary studies in Chapters 2 and 3 indicate great potential for use of the Solv-IR 
instrument in pharmaceutical chemistry, especially to study dissolution of pharmaceutical 
formulations. Chapter 5 will address a potential application of this instrument in the study of 
the chemistry behind oil spills. 
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This instrument development proposal aims to construct a new type of instrument that will 
allow the study of solvation of solutes in aqueous and organic systems. The main feature of 
the instrument design is the use of infrared (IR) spectroscopy to study this dynamic behavior. 
Traditionally, IR is not considered to be a quantitative technique. However, using A TR 
crystals ensures that the technique is most certainly quantitative. Also, IR is traditionally not 
considered to be a sensitive method, however, our preliminary results indicate detection limits 
of 10-4 M. Employing better optics and detection will improve sensitivity to our target value 
of 10-6 M. The instrument has an additional feature which may seem strange to most chemists 
as it will have six reaction vessels. This feature is important for statistical reasons and for 
marketing reasons. Solvation is a chemically and mechanically complex process. To ensure 
accurate studies of the solvation process, it is important to have a large array of data such that 
statistically significant interpretations can be made. In addition, competing instruments that 
use UV-Vis technology have six reaction vessels so they conform to certain regulatory 
requirements. 
We propose to assemble the instrument using commercially available components. We will 
build to spectroscopic part of the instrument starting with this unit. In addition, we feel that 
we work with their data acquisition software to incorporate instrument control and data 
processing. Finally, we will construct the reaction vessels, stirring function and thermal 
control and integrate this unit with the spectroscopy unit to have a fully functioning integrated 
Solv-IR instrument. 
Students working on this project will obtain valuable experience on working with electrical, 
optical and mechanical parts and tools which is quite rare for a chemistry student. However, 
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since this is all focused on discovering new ways to study the fundamental and practical 
aspects of solvation chemistry, this will be an exciting and worthwhile challenge. While 
assembling the instrument students will be able to investigate chemical phenomenon in a way 
that has been previously inaccessible. 
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5 	 Analysis of the BP Gulf oil spill by Attenuated Total 
Reflection-Infrared Spectroscopy and Dissolution 
This chapter focuses on describing the scientific research that was conducted on the recent BP 
oil spill in the Gulf of Mexico. Moreover, this research was accomplished using the React-IRI 
dissolution system. Although the BP oil spill occurred outside of New Orleans, Seton Hall 
University employed its faculty members, students and research facilities toward 
understanding this environmental disaster. 
A general background on the BP oil spill will be provided to gain more understanding of the 
subject matter, which will be useful when discussing the results later in the chapter. The BP 
oil spill (also referred to as the Deepwater Horizon oil spill, Gulf of Mexico oil spill or 
Macondo blowout), is the largest accidental marine oil spill in the history of the industry. The 
Deepwater Horizon was a nine-year drilling unit that was floating in the Gulf of Mexico. 
Refer to Figure 5-1 for a photo of Deepwater Horizon before the accident occurred. The spill 
occurred on April 20, 2010 due to an explosion of the Deepwater Horizon. This led to a loss 
of 4.9 million barrels of crude oil to the ocean. As a result, the spill caused extensive damage 
to the fishing and tourism industries around the Gulf of Mexico. 
I 
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Figure 5-1 Photo of oil rig similar to Deepwater Horizon70 
70 Photo obtained from Lauren Michael Ridley during her NOAA trip to Gulf (obtained July 2011). 
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PETROLEUM AND CRUDE OIL 
Both crude oil and natural gas are mostly made up of hydrocarbons. The lighter hydrocarbons 
which include methane, ethane, propane and butane occur as gases, while the heavier 
hydrocarbons (Le., pentane and higher) occur in the form of liquids or solids. The 
hydrocarbons in crude oil are mostly alkanes, cycloalkanes and several aromatic 
hydrocarbons. Moreover, other organic compounds contain nitrogen, oxygen and sulfur, and 
trace amounts of metals such as iron, nickel, copper and vanadium. 
5.1 Research with React-IR 
As part of the multidisciplinary project to understand the effect of the oil spill, the React-IR 
system coupled to a dissolution system was used to study the dispersion effect of dispersants 
on crude oil. Dispersants were used to break up the Deepwater Horizon oil spill before it 
reached the shore. The dispersants are designed to break down the crude oil into tiny drops, 
which can be mechanically dispersed or consumed by bacteria. The aim is to lessen the 
impact of giant plumes of crude oil washing onto oyster beds and birds' nests and on the 
sandy beaches. The dispersants or chemicals used in the BP oil spill could also do more 
damage than good in the long run. The dispersants are toxic in nature and could have 
devastating effects on future generations of marine life. The financial cost of using these 
dispersants could run into the millions. Some of the chemicals used in commercial 
dispersants71 are shown in Table 5-\. This information was obtained from the EPA website. 
71 Environmental Protection Agency Home Page. http://www.epa.gov/bpspill/dispersants-qanda.html#list 
(accessed May 1,2011). 
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Specifically, the system was used to study dispersion of oil in the presence of dishwashing 
soaps as preliminary models for commercial dispersants. From these preliminary experiments, 
the research was able to measure the effect of dispersants on petroleum oil. In addition, these 
preliminary experiments were able to determine the feasibility of the technique in order to 
move forward with the project at a larger scale. This would include purchasing commercial 
dispersants. Furthermore, Dawn® dishwashing soap was used because of its powerful claim 
to clean wildlife affected by oil spills. Dawn® specifically uses anionic surfactants, such as 
alkyl dimethyl amine oxide, to break down oil samples. These surfactants reduce the surface 
tension of water and can weaken the barrier that automatically forms between oil and water, 
allowing them to unnaturally mix. 
[115] 
---_._------
Seton Hall University 
Table 5-1 Chemicals used in commercial dispersants (COREXIT 9500 and 9527) 
CAS Registry Number 
~....... 
Chemical Name 
57-55-6 1.2-P\v.....,'cJiol 
I 
• 111-76-2 Ethanol. 2-butoxy-* 
577-11-7 Butanedioic acid. 2-sulfo-. 1.4-bis(2-ethylhexyl) ester. sodium salt (1 :1) 
1338-43-8 Sorbitan. mono-(9Z)-9-octadecenoate 
9005-65-6 
I 
Sorbitan. mono-(9Z)-9-octadecenoate, poly(oxy-1 ,2-ethanediyl) derivs. 
. 9005-70-3 Sorbitan, tri-(9Z)-9-octadecenoate, poly(oxy-1 ,2-ethanediyl) derivs 
29911-28-2 
64742-47-8 
2-Propanol, 1-(2-butoxy-1-methylethoxy)­
Distillates (petroleum), hydrotreated light 
"'This ingredient is present in 9527 but is eliminated in 9500. 
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5.2 Experimental section 
5.2.1 Chemical and materials 
Crude oil samples were collected by Dr. John Sowa and University of New Orleans scientists 
from a location near the city of Venice, Louisiana. Refer to the figures below showing the 
locations where the oil samples were collected. The University of New Orleans faculty 
collected samples from the Gulf of Mexico. The location of the samples collected was 
determined by GPS at the following location: 28° 53.412'N, 89° 08.780'W. Methanol, 
acetone and acetonitrile (HPLC grades) were purchased from Pharmaco-Aaper. Dawn® 
Antibacterial and Ultra Joy® (lemon scent) dishwashing detergent soaps were used as the 
dispersants for this research. All solutions were prepared using water treated by a MiIli-Q 
Millipore purification system. All purified water aliquots have resistivity of not less than 18 
MOhm-cm-1• 
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Figure 5-2 Aerial view:72 location of BP Gulf oil samples 
72 GoogJe Maps: http://maps.googie.com/maps?hl=en&tab=wl (accessed May 1,2011). 
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Figure 5-3 Zoom view: location of BP Gulf oil samples [Both samples were 
collected near the UNO site] 
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Figure 5-4 Ocean depth diagram73 showing location of BP Gulf oil samples 
(reproduced and modified from Ref 73) 
sea surface 
.. ' • /oil droplets 
• 
-neutral 
buoyancy 
level 
jet 
bottom sediment near-field far-field ,,, II" 
73 Figure obtained from http://www.crrc.unh.edu/finallYapa2003finallfigure I.jpg (accessed May, 2011). 
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5.2.2 Instrumentation 
Samples were tested using Mettler Toledo's iCIO FT-IR system using a fiber optic probe 
equipped with a 1 mm diamond coated A TR probe. The IR system was operated by Mettler 
Toledo's iC IR version 3.0 or 4.0 software. All dissolution experiments were tested using a 
Vankel Dissolution Bath (model no. 700). All UVNisible testing was carried out using HP 
8453 spectrophotometer. All analytical weight measurements were carried out using Mettler 
Toledo's DeltaRange and AG204 DeitaRange. 
Figure 5-5 Instrument photo: A TR-IR and dissolution apparatus 
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Table 5-2 Experimental details and sample information 
No. 
. 1 Vessel I 
2 Medium Distilled water 1 
13 Agitation speed 100 rpm 
4 Temperature 25°C 
! 
5 Dawn®! Joy® Dishwashing detergents 0.2% solutions 
.6 Dissolution bath VanKel VK700 
i 
7 ATR-IR Mettler Toledo iC 10 
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5.2.3 Dispersant stock solution 
A 0.2% solution of Dawn® dishwashing solution was made up (0.2 mL was added to 
approximately 120 mL of distilled water). A 0.2% solution of Joy dishwashing solution was 
made up (2 mL into 1000 mL of distilled water). 
5.2.3.1 Dawn® ingredients: 
Water, Sodium Lauryl Sulfate, Sodium Pareth-23, Sulfate C-12-14-16, Dimethyl Amine 
Oxide, SD Alcohol, Undeceth-9, Propylene Glycol, Cyclohexandiamine, Polyacetate, 
Protease, Fragrance, FD&C blue, no phosphate. 
5.2.3.2 Joy ingredients: 
Water, Sodium Lauryl Sulfate, Sodium Pareth-23 , C 12-14-16 Dimethyl Amine Oxide, SD 
Alcohol 40-B , Undeceth-9 , PPG-26 , Sodium Chloride, Cyclohexanediamine , Polyacetate , 
Fragrance, FD&C Yellow #5, D&C Red No. 33 
5.2.4 Crude oil sample preparation 
The dispersion experiments were carried out by adding different amounts of Dawn® 
dishwashing detergent in vessels containing 900 mL of distilled water and five (5) grams of 
semi-solid oil sample. Photographs of the oil dispersion studies were collected at different 
time points throughout the runs. The dispersion experiments were carried out over two hours. 
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5.2.5 ATR-IR analysis 
The ReactIRTM iC I 0 FTIR instrument is composed of an MCT detector (liquid nitrogen 
cooled) and the FiberConduit™. The FiberConduit™ is comprised of flexible IR transparent 
silver chloride/silver bromide optical fibers. The fiber optic probe interface (AgX 9.5 mm x 
1.5 m Fiber (Silver Halide)) contains a diamond tip-DiComp ATR crystal. The resolution was 
set to 8 wavenumbers. The optical range used by the system is: 1900 cm- I to 650 cm- I . The 
gain adjustment was set to normal (l x) and the apodization method was set to Happ-Genzel. 
The system uses compressed air (house air, filtered and de-humified) to purge the optics. 
5.3 Results 
The experiments in this chapter demonstrate how ATR-IR may be used in the study of 
treatments of oil spills. During the BP oil spill, the use of dispersants at the well-head and on 
the ocean surface was extremely controversial. Thus, this research was interested in finding 
ways to evaluate this treatment process. Although the commercial dispersants were not used 
in this research, dishwashing soaps were used as preliminary models. The results show that it 
takes considerable time for the oil to be broken down by the dishwashing soaps. Controlled 
dissolution experiments were carried out in an attempt to simulate the dispersion of oil as it 
occurred during the oil spill. The dissolution experiments were tested over the course of 
several hours and were held under elevated agitation conditions and at 25°C. These 
parameters were used in order to simulate the conditions of the ocean water in the Gulf of 
Mexico. In all of the dispersion experiments a known amount of crude oil was added to the 
dissolution vessel. Dispersants were then added and the experiments were monitored over 
several hours. During this time several photos were taken to compare and record the size of 
I 
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the crude oil samples. Moreover, the ATR-IR probe was placed in the vessel as a way to 
monitor the release of oil within the vessel as a consequence of dispersant in solution. 
5.3.1 Standards and expected absorption values 
Standard spectra of crude petroleum oil were obtained during this phase of the research. 
Crude oil is expected to have prominent IR bands at 1375 cm- l (due to methyl groups) and 
1465 ern-I (due to methylene groups). Refer to Table 5-3. Also, blank ocean solutions were 
tested to confirm there was no interference at these two FTIR bands. As shown in Figure 5-6 
below, the crude oil samples obtained by Dr. Sowa and the faculty of University of New 
Orleans show prominent peaks at 1375 and 1465 ern-I. Moreover, ocean samples obtained 
from regions under the surface oil did not show these two bands. 
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Table 5·3 Expected FT·IR stretching values for crude oil and sulfonated soaps 
I Functional 
group 
I CHz 
: 
Absorption (cm"i) 
1465 cm­i 
Description 
Methylene groups have a characteristic bending 
_ .. 
CH3 
~. 
1375 cm­1 Methyl groups have a characteristic bending 
S0 2 
1150-1165 cm­1 Symmetric stretch 
1342-1352 cm­1 Asymmetric stretch 
: 
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Figure 5·6 Gulf oil vs. blank (ocean water) standard spectra 
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Figure 5-7 Baseline corrected: ATR-IR scans of BP oil and Ocean Water samples 
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Figure 5-8 	 Photo of vessels at different time points during the dispersion 
experiments 
Time-10 minutes 	 Time: 30 minutes Time- 2 hours 
Large "clumps" formed Large "clumps" dispersed slightly Smaller "clumps" observed 
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5.3.2 Venice oil samples dispersed using Joy soap 
During the first phase of experimentation, Joy was used to simulate dispersant. 
Approximately 50 mL of the Joy stock dispersive solutions were added to different vessels 
containing 900 mL of distilled water and five (5) grams of crude oil collected near Venice, 
Louisiana. The final dispersant concentrations, compared to the concentration of commercial 
dispersants used in the ocean, are expected to be higher. The temperature was held constant 
at 25°C. The agitation speed was set to 100 rpm. Unfortunately, the Joy dispersant solution 
contained interference peaks at 1465cm-1 as shown in Figure 5-9 due to the presence of S02 
groups in the soap. 
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Figure 5-9 ATR-IR scans of Venice oil and 50 mL of Joy soap 
This figure displays A TR-IR spectra of a solution containing distilled water, Joy dispersant 
solution and crude oil collected from Venice, LA. As seen in the figure, there are several 
peaks observed between 1000 cm-! and 1500 cm-!. These peaks, moreover, increase with time. 
As discussed earlier, the peaks at 1375 cm-! and 1465 cm-] are indicative of crude oil. These 
peaks represent the methyl and methylene groups respectively. The other peaks at 1050 cm-!, 
1205 cm-! and 1254 cm-] were found in the blank solution and were attributed to the 
phosphates in Joy. 
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Figure 5-10 ATR-IR scans of 50 mL of Joy soap only (Blank solution) 
This figure displays A TR-IR spectra of a solution containing distilled water and Joy 
dispersant solution but no crude oil. As seen in the figure, there are several peaks observed 
between 1000 em-I and 1500 em-I. These peaks, moreover, increase with time_ The peaks 
observed at 1050 em-I, 1205 em- l and 1254 em-I, were attributed to the phosphates in Joy. 
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5.3.3 Venice oil samples dispersed using Dawn® soap 
Dawn® dishwashing solution was used during the second phase of the research. 
Approximately 50 mL of stock dispersive solutions were added to vessels containing 900 mL 
of distilled water and 5 grams of Venice oil. The final dispersant concentrations, compared to 
the concentration of commercial dispersants used in the ocean, were expected to be higher. 
This preliminary model, although not an exact model of the commercial setting, was 
considered a worst case scenarIo. It was considered worst case because of the higher 
concentration of dispersant used in the controlled 900 ml volume setting. The temperature 
was held constant at 25°C. The agitation speed was set to 100 rpm. Dawn® dispersant 
solutions did not give interference peaks at 1465cm-1 or extra sulfonate peaks at ~1200cm-l. 
Therefore, Dawn® dishwashing detergent soap was ultimately used to simulate the properties 
of the dispersant. 
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Figure 5-11 ATR-IR scans of Venice oil and 50 mL of Dawn® soap 
This figure displays ATR-IR spectra of a solution containing distilled water, Dawn® 
dispersant solution and crude oil collected from Venice, LA. As seen in the figure, there are 
several peaks observed between 1140 cm-I and 1520 em-I. These peaks, moreover, increase 
with time. As discussed earlier, the peaks at 1375 cm-I and 1465 cm-I are indicative of crude 
oil. These peaks represent the methyl and methylene groups respectively. 
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Figure 5-12 ATR-IR scans of 50 mL of Dawn® soap only (Blank solution) 
This figure displays ATR-IR spectra of a solution containing distilled water and Dawn® 
dispersant solution but no crude oil. 
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5.3.3.1 Percent (%) dispersant used 
An example of the percent of dispersants used during the research is shown in Table 5-4, 
Table 5-5 and Table 5-6. First, the ratio of Dawn® sample to the vessel volume is displayed 
in Table 5-4. This is represented as (A). Next, the ratio of oil to the vessel volume is 
displayed. This is represented by (B). Last, the ratio of (A) to (B) is shown in Table 5-6, 
which represents the percent dispersant calculated. 
Table 5-4 Amount of Dawn® in solution 
I Description I Amount 
Amount of Dawn® sample in solution* • 0.0017 
I Total Volume of Dawn® Solution Added (mL) 54 
I 
954• Total Volume in Vessel (mL) 
I Ratio of Dawn® sample vs. Volume in Vessel (A) 0.0001 
I 
• Approximately 0.2 ml of Oawn® Solution was added to approximately 120 ml of distilled water 
Table 5-5 Amount of BP oil in solution 
Description Amount 
Amount of Oil (Venice Samples) added (grams) 5 
Total Volume in Vessel (mL) 954 
• Ratio of Oil Sample vs. Volume in Vessel (8) 0.0052 
Table 5-6 % Dispersant calculated 
Description Amount 
Ratio of Dawn® sample vs. Volume in Vessel (A) 0.0001 
. Ratio of Oil Sample vs. Volume in Vessel (8) 
I 
0.0052 
% Dispersant calculated (A / 8) 1.8% 
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Common dishwashing detergent was found to have little affect on the dispersion of crude oil. 
As discussed earlier, dissolution experiments configured with IR spectroscopy were carried 
out whereby aliquots of crude oil were subjected to different brands of dishwashing detergent 
in order to measure and determine dispersion effect. Moreover, the dissolution experiments 
were carried out under controlled conditions in an attempt to simulate the Gulf waters. Also, 
the type of dispersant used played a major role. As shown in the figures earlier, Joy and 
Dawn® dishwashing detergents were used during this phase of the research. The Joy blanks 
solutions (did not contain crude oil), however, showed interference peaks at 1170-1270 cm,l 
and 1465 cm'l. These bands were associated to the sulfonate functional groups and methylene 
groups respectively. Dawn® blank solutions, however, did not give interference peaks at 
1465cm'I or extra sulfonate peaks at -1200 cm'l. Therefore, Dawn® dishwashing detergent 
soap was ultimately used to simulate the properties of the dispersant. The dispersion results 
clearly show that dispersion of crude oil took at least 30 minutes and up to 2 hours. 
5.3.4 Analysis by UV-Vis Spectroscopy 
In addition, the BP Oil samples were tested by UVNis spectroscopy. The objective of this 
part of the research was to determine the amount of porphyrins, if any, in crude oil.74 
Porphyrins are structurally similar to both chlorophyll and hemoglobin molecules and are 
destroyed by oxygen and heat. Porphyrins are heterocyclic macromolecules composed of four 
modified pyrrole subunits interconnected at their alpha carbon via methine bridges. These 
molecules are aromatic and highly conjugated systems. Porphyrins have very intense 
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absorption bands in the visible region. Porphyrins can also contribute to the formation of 
stable oil-in-water emulsions75 which will aid in the dispersion process. Chlorophyll, for 
example, contains several intense absorbance maximums in the region between 453 nm and 
665 nm. Refer to Figure 5-13 for a UVNis spectrum76 of chlorophyll a and b. Also, refer to 
Figure 5-14 and Figure 5-15 for chemical structures of chlorophyll a and b. 
74 Hsu, C. S.; Drinkwater, D., "Gas Chromatography Mass Spectrometry in the Petroleum Industry", in Current 

Practice of Gas Chromatography - Mass Spectrometry, W. M. A. Niessen, Ed., Chromatographic Science Series, 

Vol 86, Dekker: New York, 2001, Chapter 3, pp. 55 - 94. 

7S Lee, Richard. Agents which promote and stabilize water-in-oil emulsions. Spill Science and Technology 

Bulletin 1999, 5(2), 117-126. 

76 Figure obtained from Wikipedia [Online]. http://en.wikipedia.org/wiki/File:Chlorophyll ab spectra2.PNG 

(accessed May 1, 2011). 
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Figure 5-13 Visible spectra of chlorophy" a and b77 
chlorophyll b 
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77 Figure obtained from http://en.wikipedia.org/wiki/File:Chlorophyll ab spectra2.PNG (accessed May, 2011). 
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Figure 5-14 Chemical structure of chlorophyll a (Chern. Draw) 
o 
Figure 5-15 Chemical structure of chlorophyll b (Chern. Draw) 
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Figure 5-16 	 UVNis spectra of BP oil samples in different solvents: 1 mm cell: 
spectrophotometer fully covered from outside lighting 
No porphyrin peaks were observed for the oil samples collected. The only absorbance peaks 
that were detected were associated to interference from the trees and outside light. Refer to 
the figure below. 
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5.4 Chapter summary 
A TR-IR has been used to simulate the effects of dispersants used to treat a petroleum spill. In 
response to concerns about the use of dispersants to fight the petroleum spill in the Gulf of 
Mexico this past summer, we used ATR-IR to investigate how dispersants work. Sample of 
the BP oil were exposed to 2 wt % of commercial dishwashing soap. The studies indicate that 
the hydrocarbon components (CH2 bend at 1466 cm- I and CH3 rock at 1345 cm- I ) of the 
petroleum can be detected in the presence of the soap. However, it took more than 30 min for 
it to take effect. This is probably due to time and concentration factors to allow micelles to 
form. Moreover, this is a creative application of the React-IR concept to study the dynamic 
behavior of dispersants. Millions of dollars were spent on dispersants to alleviate and 
eliminate the spread of the BP oil to the natural coast lines. The dispersion experiments 
demonstrated that even in a controlled and accelerated laboratory environment, it still took 
several hours for the oil samples to be dispersed. Thus, one begs to question the effectiveness, 
if any, of the dispersants on the uncontrolled oil spill in the Gulf of Mexico. 
Efforts to observe the presence of chlorophyll molecules that are potentially present in the 
crude oil by UV -Vis spectroscopy were unsuccessful. At this time, the status of this 
investigation is inconclusive as the presence of these molecules in crude oil is well 
documented. It is possible that concentrations were below detection limits or the chlorophyll 
derivatives were insufficiently soluble. Although inconclusive, these investigations provide a 
foundation for future studies. 
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Research conclusions 
Dissolution studies are critical tests for measuring the performance of a drug product. In this 
dissertation, a new technique, in situ attenuated total reflection-infrared spectroscopy (ATR­
IR), has been developed to monitor dissolutions of pharmaceutical drug formulations. Two 
over-the-counter (OTC) active drugs (acetaminophen and acetylsalicylic acid) and one 
calibrator tablet (salicylic acid) were tested during the research. Moreover, both single 
component and multi-component drug formulations were tested and the individual 
components were identified by IR spectroscopy. For example, individual components of 
acetaminophen and acetylsalicylic acid in a caffeine-free formulation of Excedrin® tablets 
were easily distinguished. The ATR-IR system was found to have very good sensitivity and 
can analyze samples as low as 0.03 mg/mL (2 x 10-4 M). 
In addition, the IR system was able to distinguish separate components of a multiple 
component system without requiring manual sampling. This versatility was also demonstrated 
by observing the simultaneous dissolution of acetaminophen and salicylic acid tablets. In 
contrast, UV -Vis spectroscopy may require mathematical corrections to resolve the two active 
drugs. Furthermore, HPLC must be used which requires laborious manual sampling or 
purchase of a complicated automated instrument setup of dissolution configured with HPLC 
analysis. The in situ A TR-IR method has been validated by comparing dissolution profiles 
using UV -Vis and HPLC methods. In addition, an accuracy of ± 2 % between IR and HPLC 
for the salicylic acid results was established. With the current configuration of the IR 
instrument, this analysis is limited by the sensitivity and wavelength range of the in situ fiber 
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optic probe. However, since this chapter successfully demonstrates the versatility ofthis novel 
application of ATR-IR spectroscopy, it is clear that the method has excellent potential to be 
improved by modification of the IR instrument and selection of more sensitive probes. 
Next, the system has the capability of monitoring drug transformations during dissolution. For 
instance, the hydrolysis of aspirin to salicylic acid was studied using this technique. The 
instrument was able to monitor the simultaneous formation and elimination of aspirin while at 
the same time monitor the formation of salicylic acid in solution. This research was possible 
because of the versatility of A TR-IR system. Specifically, the unique fingerprint region of the 
IR spectra gave detailed information about the release profile of the drug. Conventional 
methods, namely, in-situ UV-Vis, would only show the release profile of one component. 
However, peak deconvolution software can be used to analyze aspirin hydrolysis. Moreover, 
the hydrolysis and transformation of the drug from one form to another may be missed with 
conventional techniques. ATR-IR captures those minor details and displays them in the 
fingerprint region, as shown earlier in the results. The unique feature of this system is that it is 
able to detect several forms of the same drug. In other words, it was able to detect the 
formation and elimination of a pharmaceutical drug (aspirin) while detecting the formation of 
the hydrosylate of the aspirin (salicylic acid) in real4ime. In addition, this system could be 
used to study other potential transformations. One example might be the dimerization of 
acetaminophen as mentioned earlier. The novelty with this particular system is its capability 
to see drug transformations in solutions while conducting the experiment in-situ. 
Also, this system was used to support the research related to the BP oil spill. The A TR-IR 
system coupled with dissolution was able evaluate the effect of dishwashing soaps in the 
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dispersion of crude oil and the results call into question the efficacy of application of 
dispersants in certain situations. 
Lastly, a new instrument design was proposed and discussed in this thesis. The proposed 
system, also known as the Solv-IR, would be built at Seton Hall University. An MRl NSF 
grant was recently filed for this proposal. The proposal to develop this instrument aims 
construct a new type of detection technique that will allow the study of solvation of solutes in 
aqueous and organic systems. 787980 The proposed unit has great potential for use in studies of 
dissolution of drugs and monitoring competing reactions such as hydrolysis of pro-drugs in 
pharmaceutical development, formulation and quality assurance. The proposed instrument 
also has application in environmental chemistry, especially to study of the fundamental 
chemistry and remediation of anthropomorphic events. 81 82 83 
7S Chen, Zeng-Ping; Morris, Julian; Borissova, Antonia; Khan, Shahid; Mahmud, Tariq; Penchev, Rado; 

Roberts, Kevin. On-line monitoring of batch cooling crystallization oforganic compounds using ATR-FTIR 

spectroscopy coupled with an advanced calibration method. Chemometrics and Intelligent Laboratory Systems 

2009,96,49-58. 

79 Wartewig, Siegfried; Neubert, Reinhard. Pharmaceutical applications of Mid-IR and Raman spectroscopy. 

Advanced Drug Delivery Reviews 2005, 57, 1144-1170. 

80 Kubicki, J.D.; Schroeter, L.M.; Itoh, M.l.; Nguyem, B.N.; Apitz, S.E. Attenuated total reflectance Fourier­

transform infrared spectroscopy of carboxylic acids adsorbed onto mineral surfaces. Geochimica et 

Cosmochimica Acta 1999, 63(18), 2709-2725. 

81 Mas, Silvia; Juan, Anna de; Tauler, Roma; Olivieri, Alejandro; Escandar, Graciela. Application of 

chemometric methods to environmental analysis of organic pollutants: A review. Talanta 2010,80, 1052-1067. 

82Varela, R.F.; Rodriguez, D.S.; Carracedo, M.P.; Andrade, J.M.; Fernandez, Muniategui, S.; Prada, D. 

Screening the origin and weathering of oil slicks by attenuated total reflectance mid-IR spectrometry. Talanta 

2005,68116-125. 

83 Varela, R.F.; Carracedo, M.P.; Rivera, P.F.; Andrade, J.M., Muniategui, S.; Prada, D. Monitoring 

photooxidation of the Prestige's oil spill by attenuated total reflectance infrared spectroscopy. Talanta 2006,69, 

409-417. 
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Appendix [A]: In situ ATR-IR Spectroscopy and Dissolution 
Data 
The chart below is an example of the digitized data that is obtained for the calibration of 
salicylic acid using A TR-IR. The data corresponds to Figure 2-1 in Chapter 2. 
Salicylic Acid Linearity Raw Data 
l M N 0 P Q R S 
WlMIflUmber (cm-1) Std·1 Sld-2 Std·3 Std-4 Std-5 Std-6 Std-7 
2 1899.4378 0.001186 0.000446 0.000116 0.000126 0.000327 0.000332 -Q.00013 
3 
.­
1895.7061 
1891.9744 
0.000956 
0.001085 
0.000368 
0.000601 
2.97E-Q5 
0.000275 
6.36E-Q5 
5.67E-Q5 
-Q.oool 
-HE-05 
-2.8E-Q5 
-QOOO21 
-Q.00048 
-Q.00061 
5 1888.2427 0.00135 0.000766 0.000266 0.000206 ~.9E-Q5 -Q.0001 -Q.00035 
6 1884.511 0.001409 0.000702 0.000398 8.74E-06 -Q00021 0.000126 602E-Q5 
7 1880.7793 0.001273 0.000655 0.000511 7.17E-06 -Q.00016 0.000112 0.000106 
8 18n.0476 0.001176 0.000475 0.000361 0.000187 3.85E-Q5 -91E-Q5 0.000104 
9 1873.3159 0.000934 0.000146 ·3.1E-Q5 -Q.00017 5.28E-Q5 -0.00037 5.46E-Q5 
10 1869.5842 0.000714 0.00013 -Q.00018 -Q.00025 -Q.00018 -Q00035 -Q'00013 
11 1865.8525 0.000853 0.000385 0.000114 0.000137 ~.6E-05 -7E-Q5 -Q'00018 
12 1862.1208 0.000974 0.000557 0.00033 0.000109 7.95E-Q5 -92E-Q5 -Q.00014 
13 1858.3891 0.001009 0.000404 0.000217 -000014 -6.7E-05 -Q.00033 -Q.00025 
14 1854.6574 0.001254 0.000447 0.000337 0.000101 0.000163 -98E-Q5 -Q.00016 
15 1850.9256 0.001315 0.000639 0.00059 0.000189 0.000494 0.00038 0.000282 
16 1847.1939 0.000906 0.000532 0000408 0.000194 0.00038 0.000376 0.000391 
17 1843.4622 0.000585 0.000351 6.54E-Q5 0.000176 -2.1E-05 -0.00017 -4.1E-Q5 
18 1839.7305 0.000589 0.000239 7.59E-Q5 0.000164 -Q.00012 -Q.00024 -Q.00028 
19 1835.9988 0.000927 0.00026 0.0004 0.000308 0.000295 0.000233 0.000175 
20 1832.2671 0.00112 0.000365 0.000567 0.000381 0.000366 0.000376 0.000426 
21 1828.5354 0.001019 0.000457 0.000329 0.000243 0.000125 0.000229 0.000222 
22 1824.8037 0.000767 0.000366 0.00014 7.26E-06 5.94E-Q5 -0.00013 4.6E-Q5 
23 1821.072 0.000492 0.0001 -5E-05 -Q.00022 -Q.0002 -0.00044 -Q.00026 
24 1817.3403 0.000374 -Q.oooll -0.00023 -Q.00027 -0.00034 -0.00043 -0.0004 
25 1813.6086 0.000341 -4.6E-Q5 -Q.OOO19 -7. 1E-Q5 -Q00019 -Q.0002 -Q.0002 
26 1809.8769 0.000349 -1.3E-05 -0.0002 ~E-06 -Q.00023 -0.00015 -Q.00024 
27 1806.1452 0.000152 -5.9E-05 -0.00019 -3.2E-Q5 -Q.OOOll -9.6E-05 -Q.0002 
28 1802.4135 0.000112 ·1.7E-05 -0.00012 ~E-Q5 5.51E-Q5 1.67E-05 -6.1E-05 
29 1798.6818 0.000295 0.000206 6.25E-Q5 5.22E-Q5 0.000209 0.000276 0.000301 
30 1794.9501 0.000326 0.000391 0.000215 0.000247 0.000343 0.000462 0.000572 
31 1791.2184 0.000106 9.28E-Q5 6.69E-06 -5.5E-Q5 6.09E-Q5 5.69E-05 0.000151 
32 1787.4867 0.000117 4.11E-06 -9.7E-05 -Q.0002 -Q.00013 -0.00017 -9.8E-Q5 
33 1783.755 0.000426 0.000234 0.00014 9.9E-05 2.59E-Q5 -5E-05 -2.2E-Q5 
34 1780.0233 0.000404 0.000284 0.000199 0.000391 0.000302 0.000199 0.00021 
35 1776.2915 0.000371 0.000486 0.000451 0.000764 0.000605 0.000895 0.000987 
36 1772.5598 0.000245 0.000244 0.000312 0.000401 0.000523 0.000637 0.000742 
37 1768.8281 3.88E-05 -7.4E-05 3.94E-06 -Q.00012 0.000101 0.00011 0.00013 
38 1765.0964 -6.3E-05 -2.1E-05 9.21E-06 -Q.00015 0.000165 000013 0.000171 
39 1761.3647 -Q.00016 -2E·05 -2.3E-Q5 -9.5E-Q5 6.08E-Q5 6.12E-05 0.000174 
40 1757.633 -Q.00019 8.03E-05 5.82E-Q5 0.000166 0.000218 0.000284 0.000409 
41 1753.9013 -Q.00029 0.000117 0.000191 0.000436 0.000616 0.000827 0.000916 
42 1750.1696 -Q.00049 -Q00017 9.82E-06 9.82E-05 0.000345 0.000517 0.000566 
43 1746.4379 ·0.00056 -Q.00027 -0.00012 -1.9E-05 0.00025 0.000287 0.000317 
i 44 1742.7062 -Q.00051 -8.6E-05 -3.5E-Q5 0.000333 0.000621 0.000642 0.00077 
45 1738.9745 -Q.00046 0.00021 0.000433 0.000988 0.001429 0.001708 0002004 
46 1735.2428 -Q.OOO63 0.000101 0.000445 0.000915 0.001478 0.001787 0.001949 
47 1731.5111 -Q.00103 -Q.00055 -0.00038 -Q.00015 0.000226 0.00019 0.000184 
48 1727.1794 -0.0011 ·0.0006 ·0.00057 -Q.00043 -Q.0002 -Q.0003 -Q.00019 
49 1724.0477 -Q.00102 -Q.00026 ~.8E-06 0.000193 0.000553 0.00063 0.000699 
50 1720.31El -Q.OOO96 3.21E-05 0.000646 0.00114 0.001678 0.002053 0.002386 
51 1716.5843 -0.00101 -Q.00022 0.000232 0.000695 0.001058 0001399 0.00156 
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Salicylic Acid Linearity Raw Data 
87 
56 
57 
56 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
: 78 
79 
80 
81 
82 
83 
84 
85 
186 
90 
91 
92 
: 93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
l 
1712.8526 
1709.1209 
1705.3892 
1701.6574 
1697.9257 
1694.194 
1690.4623 
1686.7306 
1682.9989 
1679.2672 
1675.5355 
1671.8036 
1668.0721 
1664.3404 
1660.6087 
1656.877 
1653.1453 
1649.4136 
1645.6819 
1641.9502 
16382185 
1634.4868 
1630.7551 
1627.0234 
16232916 
1619.5599 
1615.8282 
1612.0965 
1608.3648 
1604.6331 
1600.9014 
1597.1697 
1593.438 
1589.7063 
1585.9746 
15822429 
1578.5112 
1574.7795 
1571.0478 
1567.3161 
1563.5844 
1559.8527 
1556.121 
1552.3893 
1548.6575 
1544.9258 
1541.1941 
1537.4624 
1533.7307 
1529.999 
1526.2673 
M 
-(loo135 
-0.00169 
-0.00158 
-0.00137 
-0_00151 
-0.00179 
-0.00172 
-0.00149 
-0.00136 
-0_00103 
-0.00058 
-0.00026 
-0.00024 
-1.8E-05 
0.000598 
0.001461 
0.002052 
0.002549 
0.002871 
0.003484 
0.004217 
0.004913 
0.005507 
0.005408 
0.005116 
0.004863 
0.004013 
0.003593 
0.003529 
0.003243 
0.003843 
0.004418 
0.00446 
0.004379 
0_004226 
0.004503 
0.00481 
0.004666 
0.004259 
0.003809 
0.003742 
0.003015 
0_002047 
0.001426 
0.000831 
0.000738 
0.000631 
1.89E-05 
-0.00042 
-0.00041 
-0.00028 
N 
-0.00057 
-0.00061 
-0.00028 
-6.4E-05 
-0.00049 
-0.00087 
-0.00044 
6.36E-05 
-0.00022 
-0.00018 
0.000105 
0.00024 
0.000271 
0.000317 
0.000614 
0.001521 
0.001872 
0.002015 
0.001834 
0.001966 
0.002804 
0.003363 
0.003671 
0.003017 
0.00253 
0.002607 
0.002211 
0.002006 
0.001883 
0.001683 
0.001906 
0.002021 
0.002019 
0.002145 
0.001989 
0.002447 
0.002972 
0.002667 
0.00225 
0.002204 
0.002966 
0.002666 
0.001626 
0.000998 
0.000796 
0.001292 
0.00126 
0.000407 
-8.7E-05 
1.6E-05 
0.000454 
0 
-0.00028 
-0.0004 
0.000105 
0.000622 
0.000211 
-0.00035 
0.000117 
0.000642 
0.000184 
0.000147 
0.000503 
0.000747 
0.000683 
0.000337 
0.000603 
0.001783 
0.001991 
0.001953 
0.001371 
0.001583 
0.002488 
0.002566 
0.002571 
0.002313 
0.002077 
0.002114 
0.001505 
0.001433 
0.001704 
0.001429 
0.001293 
0.001197 
0.001239 
0.001421 
0.001427 
0.002033 
0.002495 
0.002121 
0.001758 
0.001733 
0.002804 
0.002645 
0.001474 
0.000854 
0.000863 
0.001712 
0.001695 
0.000636 
6.67E-05 
0.000245 
0.000897 
P 
-8.4E-05 
-8.9E-05 
0.000678 
0.001256 
0.000605 
-0.0003 
0.000371 
0.001131 
0.000488 
0.000437 
0_000868 
0.001202 
0.001076 
0.000815 
0.001152 
0.002499 
0.002544 
0.002269 
0.001695 
0.001557 
0.002059 
0.002168 
0.002323 
0.0019 
0.001755 
0.002018 
0.001531 
0.001264 
0.001158 
0.000724 
0.000651 
0.000801 
0.000974 
0.001154 
0.001185 
0.001804 
0.002395 
0.001997 
0.001532 
0.001662 
0.00323 
0.003158 
0.001614 
0.000824 
0.00107 
0.002334 
0.002244 
0.00103 
0.000373 
0.000508 
0.001294 
Q R S 
0.000218 0.000394 0.000496 
0.000276 OJ)()0494 0.000667 
0.001315 0.001761 0.002152 
0.002196 0.002715 0.003221 
0.001399 0.001807 0.00208 
0.000253 0.00053 0.000575 
0.001154 0.001581 0.001793 
0.002001 0.002561 0.002855 
0.00093 0.001237 0.001419 
0.000719 0.001093 0.0014 
0.001316 0.001638 0.001966 
0.001627 0.001811 0.001981 
0.001491 0.001617 0.001777 
0.001329 0.001406 0.00168 
0.001739 0.002054 0.00221 
0.003535 0.004215 0.004565 
0.003286 0.003881 0.00432 
0.002765 0.003057 0.003508 
0.002215 0.002284 0.00251 
0.001868 0.001993 0.002262 
0.002582 0.002784 0.003125 
0.002763 0.0025 0.00276 
0.002625 0.002211 0.002611 
0.002059 0.001872 0.002161 
0.002031 0.001956 0.002238 
0.0023 0.002298 0.002563 
0.001478 0.001332 0.001496 
0.00118 0.001062 0.001137 
0.001232 0.00126 0.001033 
0.000871 0.000978 0.00065 
0.000812 0.000723 0.0006 
0.000832 0.000642 0.000628 
0.000834 0.000778 0.000709 
0.001034 0.000973 0.000692 
0.001046 0.000976 0.000783 
0001956 0.001973 0.002109 
0.002826 0.002929 0.003247 
0.00223 0.002352 0.002464 
0.00166 0.001823 0.001755 
0.00187 0.002077 0.002042 
0.00381 0.004369 0.004606 
0.003769 0.004346 0.004669 
0.001894 0.00218 0.002324 
0.000991 0.00114 0.001238 
0.001416 0.001524 0.001795 
0.003066 0.003471 0.003976 
0.003061 0.003621 0.003955 
0.001535 0.001916 0.001958 
0.000723 0.000964 0.000992 
0.001002 0.001193 0.001353 
0.002015 0.002362 0.002688 
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104 
105 
106 
101 
108 
109 
110 
111 
11 
6 
117 
118 
119 
120 
121 
122 
121 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
14 
145 
146 
147 
148 
149 
150 
15 
152 
153 
L N 0 P a R S 
1522.5356 
1518.8039 
1515.0122 
1511.3405 
1501.6088 
1503.8111 
1500.1454 
1496.4131 
1492.682 
1488.9503 
1485.2186 
1481.4869 
1477.7552 
1474.0234 
1470.2917 
1466.56 
1462.8283 
1459.0966 
1455.3649 
1451.6332 
1441.9015 
1444.1698 
1440.4381 
1436.1064 
1432.9147 
1429.243 
1425.5113 
1421.1796 
1418.0479 
1414.3162 
1410.5845 
1406.8528 
1403.1211 
1399.3894 
1395.6576 
1391.9259 
1388.1942 
1384.4625 
1380.1308 
1316.9991 
1313.2614 
1369.5357 
1365.804 
1362.0723 
1358.3406 
1354.6089 
1350.8112 
1347.1455 
1343.4138 
1339.6821 
1335.9504 
-0.00061 
-0.00012 
-0.00043 
-0.00021 
-0.0001 
0.000916 
0.003351 
0.006785 
0.001163 
0.004093 
0.001505 
0.000584 
0.000399 
0.000651 
0.002111 
0.006014 
0.006588 
0.003853 
0.001528 
0.000208 
-0.00029 
-0.00025 
-0.00035 
·0.00039 
-0.00031 
-0.00023 
9.44E-05 
0.000413 
0.000783 
0.001229 
0.001582 
0.00238 
0.00411 
0.00123 
0.010625 
0.011517 
0.009322 
0.006639 
0.004745 
0.003576 
0.002964 
0.002925 
0.00319 
0.003132 
0.003297 
0.003966 
0.004446 
0.004486 
0.004391 
0.003976 
11 
-000012 
-000024 
0.000349 
0.000441 
0.000149 
0.000788 
0.001924 
0.003629 
0.0031 
0.001919 
0.000668 
0.000497 
0.000456 
0.000365 
0.001411 
0.003346 
0.003804 
0.00205 
0.00068 
-0.00012 
-0.00043 
-000021 
-000021 
-0.0002 
-0.00012 
-5.6E-05 
0.00021 
0.000187 
0.000316 
0.000692 
0.000908 
0.001332 
0.00226 
0.003786 
0.005419 
0.005803 
0.00456 
0.003193 
0.002303 
0.001644 
0.00128 
0.001388 
0.001619 
0.001462 
0.001511 
0.002018 
0.002376 
0.002431 
0.002383 
0.002084 
0'()()08B3 
0.000213 
0.000111 
0.000883 
0.000962 
0.000393 
0.000863 
0.001548 
0.002652 
0.002682 
0.001384 
0.000422 
0.000561 
0.000678 
0.000351 
0.001032 
0.00261 
0.003064 
0.001519 
0.000414 
-0.00019 
-0.00044 
-7E-05 
-39E-05 
-0.00015 
-5.3E-05 
1.21E-05 
0.000361 
0.000263 
0.000287 
0.000593 
0.000738 
0.001071 
0.001145 
0.002654 
0.003111 
0.003926 
0.002895 
0.002056 
0.001541 
0.001055 
0.00069 
0.000801 
0.001039 
0.000881 
0.000896 
0.001364 
0.001719 
0.001152 
0.001119 
0.001469 
O. 1 18 
0.000559 
0.000303 
0.001316 
0.001496 
0.000684 
0.000905 
0.001223 
0.002141 
0.002235 
0.001053 
0.000392 
0.00091 
0.000891 
0.000312 
0.001008 
0.002558 
0.003025 
0.001511 
0.000513 
-0.00013 
-0.00056 
-0.00018 
--S.2E-05 
-4E-05 
0.000113 
0.000328 
0.000549 
0.000111 
5.03E-05 
0.000356 
0.000409 
0.000714 
0.001243 
0.001951 
0.00305 
0.003381 
0.002381 
0.001641 
0.001224 
0.0001 
0.000491 
0.000181 
0.000891 
0.000669 
0.000839 
0.001218 
0.001276 
0.001346 
0.00129 
0.000776 
0.001992 0.002411 0.002148 
0.001058 0.001415 0.00154 
0.000164 0.001019 0.001165 
0.002082 0.002589 0.002924 
0.002189 0.002101 0.00305 
0.00106 0.001374 0.001435 
0.001411 0.001686 0.001733 
0.001588 0.001689 0.001733 
0.002244 0.002175 0.002169 
0.002164 0.001911 0.001924 
0.001048 0.000952 0.000819 
0.00055 0.000608 0.000618 
0.001281 0.001501 0.001614 
0.001312 0.001515 0.001108 
0.000586 0.000659 0.000113 
0.001056 0.001119 0.00106 
0.00258 0.002668 0.002682 
0.003316 0.003411 0.003606 
0.001121 0.001169 0.001768 
0.000609 0.000658 0.000649 
-7.4E-05 3.63E-05 1.82E-05 
-0.00048 -000034 -0.00034 
9.85E-05 0.000275 0.000414 
0.000156 0.000341 0.000446 
5.78E-05 0.00016 0.000119 
0.000152 0.000237 0.000254 
0.000428 0.000585 0.000652 
0.000894 0.001073 0.001228 
0.000443 0.000471 0.000569 
0.000194 0.000178 0.000115 
0.000466 0.000553 0.000449 
0.000584 0.000648 0.00062 
0.000883 0.00092 0.000919 
0.001327 0.001341 0.001324 
0.001154 0.001637 0001532 
0.002591 0.002352 0.002151 
0.002882 0.002586 0.002351 
0.001961 0.001106 0.001443 
0.001377 0.00123 0.000992 
0.00108 0.000948 0.000799 
0.00067 0.000572 0.000445 
0.000432 0.000431 0.000326 
0.000661 0.000681 0.000613 
0.000115 0.000148 0.000721 
0.000565 0.000511 0.00045 
0.000104 0.000643 0.000525 
0.001046 0.000987 0.00081 
0.001214 0.001134 0.001006 
0.001331 0.001206 0.001113 
0.001206 0.001142 0.001091 
0.000144 0.000645 0.000552 
[1481 
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l M N 0 P Q R S 
1332.2187 0.00338 0.001653 0.001025 0.000664 0.000468 0.000352 0.000257 
155 1328.487 0.002996 0.001477 0.000908 0.000941 0.000618 0.000534 0.000424 
156 1324.7553 0.002511 0.00119 0.000724 0.000769 0.000566 0.000513 0.00043 
157 1321.0235 0.002244 0.001047 0.000652 0.00052 0.000495 0.000449 0.000424 
158 13172918 0.002288 0.001121 0.000739 0.000519 0.000533 0.000496 0.000473 
159 1313.5601 0.002267 0.001008 0.000576 0.000396 0.000379 0.000356 0.000295 
160 1309.8284 0.002465 0.001017 0.000567 0.000432 0.000423 0.000394 0.000312 
161 1306.0967 0.002911 0.001308 0.000842 0.000661 0.000678 0.000606 0.000501 
162 1302.365 0.003314 0.001634 0.001101 0.000778 0.000716 0.000635 0.000505 
163 1298.6333 0.003299 0.001693 0.00116 0.000854 0.000696 0.000622 0.000489 
164 1294.9016 0.003022 0.001543 0.001068 0.000843 0.000789 0.000736 0.000598 
165 1291.1699 0.002832 0.001469 0.001037 0.000822 0.000878 0.000635 0.000737 
166 1287.4382 0.002753 0.001452 0.001042 0.000799 0.00074 0.000701 0.0006 
167 1283.7065 0.002886 0.001571 0.001151 0.000807 0.000676 0.00062 0.000497 
168 1279.9748 0.00303 0.001679 0.00123 0.000866 0.000823 0.000751 0.000679 
169 12762431 0.00309 0.001643 0.001152 0.000976 0.000917 0.00065 0.000804 
170 1272.5114 0.00324 0.001658 0.0011 0.000864 0.000866 0.000768 0.000716 
171 1268.7797 0.003783 0.00191 0.001298 0.000783 0.000866 0.000731 0.00064 
172 1265.048 0.004695 0.002387 0.001656 0.001061 0.00095 0.000795 0.000701 
173 1261.3163 0.005823 0.002982 0.002023 0.001436 0.001121 0.000989 0.000863 
1174 1257.5846 0.006738 0.003401 0.00223 0.001667 0.001343 0.001195 0.00103 
175 1253.8529 0.006747 0.003343 0.002168 0.001566 0.001244 0.001031 0.000874 
176 1250.1212 0.005908 0.002911 0.001931 0.001398 0.001088 0.000919 0.000748 
177 1246.3894 0.004836 0.00232 0.001482 0.001029 0.000816 0.000698 0.000495 
178 1242.6577 0.004405 0.002154 0.001394 0.000901 0.000741 0.000629 0.00045 
179 1238.926 0.00419 0.002078 0.001404 0.000894 0.000771 0.00069 0.000548 
180 1235.1943 0.003753 0.001813 0.001124 0.000674 0.000462 0.000394 0.000261 
181 1231.4626 0.003634 0.001757 0.001095 0.000713 0.000472 0.000368 0.000316 
182 1227.7309 0.003853 0.001965 0.001355 0.001022 0.000876 0.000756 0.000738 
183 1223.9992 0.00387 0.001951 0.001356 0.001098 0.001005 0.000925 0.000854 
184 1220.2675 0.003658 0.001736 0.00111 0.000889 0.000776 0.000738 0.000635 
185 1216.5358 0.003675 0.00178 0.001127 0.000979 0.000626 0.000745 0.000679 
186 1212.8041 0.003753 0.001899 0.001217 0.001156 0.001025 0.000878 0.000802 
187 1209.0724 0.003834 0.001958 0.001254 0.001085 0.000959 0.000814 0.000702 
188 1205.3407 0.003864 0.001879 0.001173 0.000842 0.000791 0.000667 0.00056 
189 1201.609 0.00397 0.00189 0.001212 0.000742 0.000797 0.000721 0.000614 
190 1197.8773 0.004257 0.002126 0.001457 0.000872 0.00093 0.000873 0.000745 
191 1194.1456 0.004628 0.002425 0.001697 0.001134 0.001031 0.000931 0.00077 
192 1190.4139 0.004976 0.002665 0.001879 0.001307 0.001027 0.000908 0.000793 
193 1186.6822 0.005204 0.00272 0.001878 0.001212 0.001006 0.000914 0.000827 
194 1182.9505 0.005668 0.002891 0.002031 0.001388 0.001294 0.001153 0.001049 
195 1179.2188 0.006234 0.003232 0.002276 0.001674 0.0015 0.001306 0.001194 
196 1175.4871 0.006604 0.003391 0.002266 0.001499 0.001286 0.001087 0.000922 
197 1171.7553 0.006879 0.003437 0.00217 0.001422 0.001196 0.000999 0.000803 
198 1168.0236 0.007416 0.003675 0.00235 0.001609 0.001364 0.001155 0.000954 
199 1164.2919 0.008204 0.00413 0.002754 0.00195 0.001723 0.001427 0.00124 
200 1160.5602 0.008411 0.004226 0.002832 0.002038 0.001825 0.001501 0.001325 
201 1156.8285 0.007971 0.003972 0.002644 0.001869 0.001626 0.00136 0.001185 
202 1153.0968 0.007722 0.003877 0.002546 0.001929 0.001639 0.001426 0.001268 
203 1149.3651 0.007602 0.003817 0.002446 0.001717 0.001408 0.001198 0.001026 
204 1145.6334 0.006491 0.003212 0.002016 0.001224 0.000872 0.000653 0.000515 
[149] 
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l M N 0 P a R s 
1141.9017 0.004839 0.002328 0.001445 0.000891 0.000551 0.000403 0.000323 
1138,17 0.003536 0.001676 0.001013 0.000684 0.000464 0.000371 0.000304 
1134.4383 0.002521 0.001262 0.000793 0.000473 0.000403 0.000311 0.000212 
208 1130.1066 0.001495 0.000142 0.000469 5.25E-05 9.44E-05 -2E-05 -1.9E-05 
209 1126.9749 2,45E-05 -0.0002 -0.00031 -0.00054 -0.00044 -0.00054 -0.00052 
210 11232432 -0.00118 -0.00018 -0.00068 -0.00059 -0.00044 -0.00044 -0.00041 
21 1119.5115 -0.00226 -0.00121 -0.00089 -0.00069 -0.00053 -0.00043 -0.00039 
212 1115.7198 -0.00371 -0.00194 -0.00142 -0.00106 -0.00092 -0.00079 -0.00015 
213 1112.0481 -0.00512 -0.00253 -0.00174 -0.00144 -0.00118 -0.00098 -0.00095 
214 1108.3164 -0.0066 -0.00314 -0.00199 -0.00193 -0.00147 -0.00121 -0.00104 
215 1104.5847 ·0.00868 -0.00424 -0.00274 -0.00242 -0.0019 -0.00161 -0.00133 
216 1100.853 -0.0111 -0.00558 -0.00374 -0.00309 -0.00241 -0.00212 -0.00181 
217 1097.1213 -0.01326 -0.00669 -0.00451 -0.00351 -0.00277 -0.00233 -0.00204 
218 1093.3895 ·0.01488 -0.00162 -000519 -0.00399 -0.00321 -0.00268 -0.00232 
219 1089.6518 -0.01538 -0.00803 -0.0055 -0.00442 -0.00361 -0.00308 -0.00269 
220 1085.9261 -0.01451 -0.00162 -000525 -0.0044 -0.00348 -0.00299 -0.00261 
221 1082.1944 -0.01219 -0.00618 -0.00468 -0.00383 -0.00291 -0.00256 -0.00122 
122 1018.4627 -0.01176 -0.00634 -0.00441 -0.0035 -000274 -0.0024 -0.00207 
223 1014.131 -0.01193 -0.0064 -0.00445 -0.00348 -0.00268 -0.00229 -0.00198 
224 1070.9993 -0.01221 -0.00643 -0.0044 -0.00335 -0.00253 -0.00214 -0.00188 
225 10672616 -0.01213 -0.00631 -0.00438 -0.0034 -0.00266 -0.00229 -0.00205 
226 1063.5359 ·0.01119 -0.00595 -0.00414 -0.00336 -0.00212 -0.00233 -0.00211 
227 1059.8042 -0.00961 -0.00508 -0.00354 -0.0029 -0.00242 -0.00203 -0.00184 
228 1056.0725 -0.00191 -0.00409 -0.00286 -0.00223 -0.00191 -0.00157 -0.00139 
229 1052.3408 -0.0063 -0.00316 -0.00217 -0.00161 -0.00142 -0.00116 -0.00099 
230 1048.6091 -0.00517 -0.00264 -0.00183 -0.00147 -0.00134 -0.00115 -0.00098 
231 1044.8774 -0.00415 -0.00211 -0.00148 -0.00134 -0.00115 -0.00099 -0.00085 
232 1041.1457 ·0.00293 -0.00138 -0.0009 -0.00086 -0.00057 -0.00048 -0.00038 
233 1037.414 ·0.00193 -0.00091 -0.00057 -0.0006 -0.00037 -0.00039 -0.00029 
234 1033.6823 -0.00152 -0.00082 -0.00055 -0.00062 -0.00045 -0.0005 -0.0004 
235 1029.9506 -0.00169 -0.00096 -0.0007 -0.0008 -0.00056 -0.00056 -0.0005 
236 1026.2189 -0.00176 -0.00099 -000075 -0.00076 -0.00054 -0.0005 -0.00046 
237 1022.4872 -0.00198 -0.00119 -0.00101 -0.00087 -0.00074 -0.00064 -0.00064 
238 1018.7554 -0.00221 -0.00136 -0.00118 -0.00104 -0.00097 -0.00083 -0.00087 
239 1015.0237 -0.00208 -0.00112 -0.0009 -0.00069 -0.00061 -0.0005 -0.00051 
240 1011.292 -0.00219 -0.0011 -0.00079 -0.00058 -0.00036 -0.0003 -0.00024 
241 1007.5603 -0.0027 -0.00139 -0.00093 -0.00095 -0.00074 -0.00064 -0.00055 
242 1003.8286 -0.00371 -0.00185 -0.00119 -0.00121 -0.0009 -0.00075 -0.00065 
243 1000.0969 -0.00586 -0.00293 -0.00196 -0.00154 -0.00098 -0.00075 -0.00062 
244 996.3652 -0.0087 -0.0044 -0.00298 -0.00219 -0.00158 -0.00118 -0.00104 
245 992.6335 -0.01057 -0.0054 -0.00367 -0.00278 -0.00122 -0.00173 -0.00152 
246 988.9018 -0.00982 -0.00499 -0.00345 -0.00255 -0.00195 -0.00155 -0.0013 
247 985.1701 -0.00724 -0.00364 -0.0025 -0.0017 -000113 -0.00087 -0.00067 
248 981,4384 -0.00489 -0.00257 -0.00178 -0.00125 -0.00083 -0.00071 -0.00055 
249 977.7067 -0.00331 -0.0018 -0.00132 -0.00096 -0.00073 -0.00062 -0.00049 
250 973.975 -0.00208 -0.00108 -0.00079 -0.00048 -0.00036 -0.00021 -0.0001 
25 970.2433 -0.00118 -000063 -0.00049 -0.00039 -0.00019 -9.2E-05 -5.6E-05 
252 966.5116 -0.00044 -0.00028 -0.00026 -0.00024 -1E-05 7.42E-05 3.01E-05 
253 962.7799 0.000815 0.000539 0.00047 0.000491 0.000655 0.000717 0.000705 
254 959.0482 0.002108 0.001349 0.001195 0.001016 0.001059 0.001048 0.0011 
255 955.3165 0.002958 0.001739 0.001411 0.000919 0,000847 0.000858 0.00087 
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Salicylic Acid Linearity Raw Data 
l M N 0 P Q R S 
951.5848 0.003795 0.002052 0.001546 0.000769 0,000633 0.00059 0,000539 
257 947.8531 0.004571 0.00237 0.001777 0.001007 0.000903 0.000774 0.000714 
258 94,4,1213 0.004691 0.002306 0.001617 0.001273 0.001165 0,001099 0.000984 
259 940.3896 0.004372 0.002068 0.001318 0.001026 0.000997 0.000965 0.000868 
260 936.6579 0.004143 0.002079 0.001323 0.000962 0.000931 0.000916 0.000862 
261 932.9262 0.003803 0.002096 0.001401 0.001324 0.00126 0.001301 0,001234 
262 929.1945 0.003135 0,001903 0.001382 0.001508 0.001561 0.001594 0,001528 
263 925.4628 0.002265 0.00147 0.001244 0.001512 0.001764 0.001758 0,001767 
264 921.7311 0.001181 0.000692 0.000776 0.001116 0.001422 0,001473 0.001564 
265 917,9994 0,000139 7,48E-05 0,000247 0,000604 0,000756 0,000895 0,000993 
266 914.2677 -0.00066 -000037 -0,0001 0,00043 0.00058 0.00072 0,000773 
267 910.536 -0.00111 -0.00055 -0,00018 0.000233 0,000703 0,000826 0,000854 
268 906,8043 -0.00145 -0.00048 -0.00016 0.000153 0.000723 0.000877 0,000917 
269 903.0726 -0.00203 -0,00074 -0,00027 0.000119 0.000555 0.000717 0.000854 
210 899,3409 -0,00255 -0.00114 -0,00047 6.33E-05 0.000483 0.000604 0.000875 
271 895.6092 -0.00298 -0.00149 -0.00071 5.53E-05 0.000489 0,000728 0.000813 
272 891.8775 -0.00341 -0.00167 -0.00085 -0.0003 0.000225 0.000674 0.000554 
273 888.1458 -0.00366 -0.00178 -0.00088 -0,0005 0,000303 0,000795 0.000705 
214 884.4141 -0.00371 -0,00176 -0.00093 -0.00054 0.00054 0.001018 0,000964 
215 880,6824 ·0.00388 -0,00205 -000119 -0.00095 2.71E-05 0.000539 0,00056 
216 876.9507 -0.00393 -0.00226 -0.00116 -0.00079 -7E-05 0.000362 0.000589 
277 873.219 -0.00433 -0.00239 -0.00119 -0.00055 0.000101 0.00032 0.000496 
218 869.4872 -0.00487 -0.00264 -0.00157 -0.0008 -SE-05 0,000167 0.000311 
219 865.7555 -0.00509 -0.00283 -0.00172 -0.00128 -0.0004 -0.00018 0.000181 
862.0238 -0.00537 -0.00265 -0.00138 -0.00101 -0,00023 0.000242 0.000488 
858.2921 -0.00619 -0,00314 -0.00166 -0.00095 -0,00016 0.000614 0.000697 
854.5604 -0.00725 -0,00408 -0.00256 -0.00151 -0.00072 -0.00019 0,000125 
850.8287 -0.00788 -0.00415 -0.00262 -0.00135 -0.00058 -0,0001 0.000241 
284 847.097 -0.00796 -0.0037 -0.00195 -0.0009 0.00016 0.000811 0.000701 
285 843.3653 -0.00754 -0.00338 -0,00168 -0.00072 0.000331 0.000964 0.001029 
286 839.6336 -0,0077 -0,00362 -0.00202 -0.00133 -0.00016 0.00029 0.000708 
287 835.9019 -0.00812 -0.00387 -0.00244 -0.00186 -0.00039 9.25E-05 0.000235 
288 832.1702 -0.00763 -0.00413 -0.00235 -0,00145 1.14E-05 0.000779 0.000564 
289 828.4385 -0.00704 -0.00427 -0.00174 -0.00094 0.000403 0.001395 0.001235 
824.7068 -0.0077 -0.00418 -0.00212 -0.00147 0.000107 0.000949 0.000877 
820.9751 -0.0082 -0.00388 -0.00268 -0.00202 -0.00054 -0.0003 -0.00029 
817.2434 -0.00781 -0.00401 -0.00245 -0.00199 -0.00124 -0.00118 -0.00075 
813.5117 -0.00678 -0.00338 -0.00158 -0.0009 -0.00054 0.000213 0.000371 
809.78 -0.00636 -0.00321 -0.00153 -0.00048 3.4E-05 0.00109 0.000918 
806.0483 -0.00736 -0.00368 -0.00201 -0.00164 -0.0004 0.000307 0.000387 
802.3166 -0.00797 -0.00406 -0.00254 -0.00259 -0.00083 -0.00051 0.000109 
798.5849 -0.00819 -0,00484 -0.00311 -0.00241 -0.00122 -0.00087 2.94E-05 
794.8532 -0.0082 -0.0049 -0.00359 -0.00217 -0.00133 -0.00064 -4.4E-05 
791.1214 -0.00786 -0.00405 -0.00322 -0.00221 -0.00135 -1.8E-05 0.000357 
787.3897 -0.00714 -000339 -0.00148 -0.00058 1.62E-05 0.000994 0.001373 
301 783.658 -0.00734 -0.00333 -0.001 0.000207 0.000315 0.001158 0.0018 
302 779.9263 -0.00693 -0.00292 -0.00114 -0.00023 -1E-04 0.000946 0.001363 
303 776.1946 -0.00613 -0,00272 -0.00141 -0.00076 0.000415 0.001108 0.001337 
304 772.4629 -0.00777 -0.00383 -0.00335 -0.00201 -7.5E-05 0.000259 0.000769 
305 768.7312 -0.00763 -0,00403 -0.00417 -0.00264 -0.00036 -0.00019 0.00045 
306 764.9995 -0.00575 -0.00161 -0.0015 -0.00051 -6.5E-05 0.001896 0.00175 
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Salicylic Acid Linearity Raw Data 
L M N 0 P a R S 
761.2678 -0.00503 -0.00106 -0.00032 0.001092 5.23E-05 0.00358 0.001615 
308 757.5361 -0.00629 -0.00331 -00015 -0.00044 -0.00015 0.003362 0.001435 
309 753.8044 -0.00683 -0.00424 -0.0015 -0.00113 0.000211 0.002343 0.003148 
310 750.0727 -0.00725 -0.00467 -0.00072 -0.00203 0.000186 0.000415 0.003189 
311 746.341 -0.00736 -0.00409 -0.00072 -0.00209 0.000299 0.000565 0.001658 
312 742.6093 -0.00727 -0.0023 -0.00152 -0.00068 0.000539 0.00208 0.001731 
313 738.8776 -0.00746 -0.00387 -0.00284 -0.0003 0.000658 0.002007 0.001217 
314 735.1459 -0.00653 -0.00268 -0.00376 0.000387 0.001801 0.002261 0.002028 
315 731.4142 -0.00631 -0.00243 -0.00418 0.000465 0.001284 0.001984 0.002449 
316 727.6825 -0.00448 -0.0036 -0.00271 0.000659 3.79E-05 0.003612 0.002328 
317 723.9508 -0.00609 -0.00211 -0.0007 0.002337 0.001633 0.004503 0.002582 
318 720.2191 -0.00823 -0.0018 -0.0018 0.003083 0.003483 0.001606 -6.5E-05 
319 716.4873 -0.01052 -0.00518 -0.00618 -0.00112 -0.00192 -0.00196 -0.00296 
320 712.7556 -0.009 -0.00408 -0.00503 -0.00335 -000193 0.000819 0.002041 
321 709.0239 -0.00263 0.002016 8.46E-05 0.000322 0.006467 0.00659 0.008253 
322 705.2922 0.000411 0.00198 0.000152 0.000988 0.008183 0.007496 0.007357 
323 701.5605 -0.00433 -0.00022 -0.00489 0.000451 0.001238 0.008372 0.003532 
324 697.8288 -0.00972 0.001882 -0.00648 -0.0021 -0.00287 0.006825 0.000633 
325 694.0971 -0.01283 0.001633 -0.00345 -0.00274 0.004553 0.003136 0.005014 
326 690.3654 -0.00477 -0.00307 0.001101 0.00155 0.015475 0.008684 0.007746 
327 686.6337 0.002714 0.004069 0.008987 0.017488 0.023048 0.017339 0.00774 
328 682.902 0.002344 0.008319 0.0125 0.019268 0.012339 0.021648 0.014214 
329 679.1703 0.01973 0.009579 0.014092 0.022671 0.006015 0.020514 0.020884 
330 675.4386 0.022907 0.027308 0.011454 0.008652 0.013533 0.00993 0.018337 
67U069 0.040395 0.047424 0.04506 0.017746 0.03161 -0.00108 0.038309 
667.9752 0.03742 0.034306 -0.0015 0.211175 0.041259 -0.00308 0.041487 
664.2435 -0.03673 0.031214 -0.10889 0.176551 -0.01099 -0.01847 -0.01638 
660.5118 -0.01329 0.05025 -0.07151 0.057809 0.006968 0.009254 -0.00372 
656.7801 0.045812 0.024709 0.032092 0.047795 0.042077 0.073839 0.0306 
653.0484 -0.04397 0.004264 0.035975 -0.03612 -0.01248 0.056891 -0.02779 
649.3167 -0.0637 0.00249 -0.C1432 -0.05065 0.00042 0.118745 0.020689 
[152J 

Seton Hall University 
Figure 7-1 	 Linearity of salicylic acid in pH 7.4 phosphate buffer (corresponds to 
Figure 2-1 in Chapter 2) 
The table below contains the raw data collected during the salicylic acid linearity experiment. 
Eight serial dilutions of salicylic acid reference standards were used during the linearity study. 
The molar concentrations are displayed in the table. Standard 1 represents about 21 mg of 
salicylic acid per 900 ml of buffer while Standard 8 represents about 300 mg of salicylic acid 
per 900 ml of buffer. Since a large salicylic acid peak was observed at 1388 em-I, a single­
point baseline correction at 1370 em-I was used to correct the data. 
Description Flask Volume (L) Concentration (M) 1388nm 1388-1370 
Std-1 0.050 0.03215 0.01152 0.00855 
Std-2 0.100 0.01607 OO51=i 0.00452 Std-3 0.150 0.01072 O.0.0039 0.00324 
Std-4 0.200 0.00804 0.0033 0.00290 
Std-5 0.250 0.00643 0.00288 0.00245 
Std-6 0.300 0.00536 0.00259 0.00215 
Std-7 0.350 0.00459 0.00235 0.00203 
Std-8'" 0.700 0.00230 0.00103 0.00118 
... Note:Conc. ~1oo% of300mg tablet In actual vessel (900ml) dIssolutIOn 
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Figure 7·2 Linear regression chart for saliyclic acid 
The figure below is a linear regression plot for the serial dilutions of salicylic acid reference 
standards. Since a large salicylic acid peak was observed at 1388 cm-1, a single-point baseline 
correction at 1370 cm-1 was used to correct the data. 
Linear Regression for Serial Dilutions of Salicylic Acid Reference Standards: 
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Figure 7-3 	 Dissolution results for salicylic acid in pH 7.4 phosphate buffer: HPLC 
vs. IR data (corresponds to Figure 2-2 in Chapter 2) 
The table below corresponds to the percent (%) dissolved data obtained from the salicylic acid 
dissolution experiment. The table compares ATR-IR to HPLC percent dissolved results. 
HPLC samples were collected after 30 min, 1 hour, 2 hour, 3 hour, 6.5 hours and finally after 
7 hours. Moreover, the samples were analyzed using an Agilent HPLC system. As shown in 
the table below the maximum absolute difference observed between the IR and HPLC data 
was found to be 3%. 
Time (hh:mm) ." Dissolved (HPlq Dissolved by(lR) Difference 
00:00 0.0% 0.0% 0% 
00:30 11.1% 14,4% -3% 
01:00 20.9% 23.1% -2% 
02:00 38.2% 38.0% 0% 
03:00 52.9% 50.9% 2% 
06:30 87.8% 88.3% -1% 
07:00 94.8% 97.8% -3% 
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Figure 7-4 ATR-IR System photo 
The figure below shows a photo of the Mettler Toledo ATR-IR system coupled with a 
DiComp fiber optic probe. The photo shows the DiComp probe inserted into a standard 
dissolution vessel. An external electric stirrer was used to control the agitation speed 
(RPM's). 
[156] 
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Figure 7-5 Mettler Toledo ATR-IRI Dissolution Systems 
The figure below shows a photo of the Mettler Toledo ATR-IR system coupled with a 
DiComp fiber optic probe. The photo shows the DiComp probe inserted into a standard 
dissolution vessel. The Vankel six-vessel dissolution system was used for during testing. 
[157] 
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Figure 7-6 Flow Cell Fiber Optic Probe: 
The figure below shows a photo of the Mettler Toledo ATR-IR system coupled with a Flow 
Cell fiber optic probe. Plumbing from the Flow Cell was attached to an Agilent six-port valve 
pump. Also, plumbing from a dissolution vessel was attached to the pump. Thus, a close-loop 
system was created whereby dissolution samples were drawn to the flow cell via the pump 
and back to the dissolution vessel. Homogeneous mixing, within the dissolution vessel, was 
achieved using a stir plate and magnetic stir bar. 
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Figure 7-7 K4 Fiber Optic Probe 
The figure below shows a photo of the Mettler Toledo A TR-IR system coupled with a K4 
Conduit fiber optic probe. The photo also shows a dissolution vessel attached to the K4 probe. 
The dissolution vessel was produced out of a methanol bottle. A valve was attached to the 
vessel in order to empty the vessel contents during dissolution runs and cleaning. 
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Figure 7-8 HPLC analysis for Salicylic Acid calibrator tablets 
Salicylic Acid Tablets (HPL.C Analysis) 
Batch No . Salicylic Acid calibrator tablets Lot # Q00200 
Sample Name Vial No. Injection RT Area !Result 10 
Standard 1 1 1 2533 0.7 4252948 
30min 2 1 2534 0.7 472913 
1 hour 3 1 2535 0.7 891091 
12 hour 4 2536 0.7 1629150 
3 hour 15 2537 0.7 2259379 
6.5 hour 0.76 3764607 
7 hour 0.77 2539 4064077 
Standard 1 1 ~1 2533 0.7 4252948 
Standard-1 Weight (mg) 6001 Standard-1 Avg Area 4252948 
Standard Declared Content (%): 1000 Std-1WtlStd-1PA 1.411.E-05 
Vessel Volume (mL) 500.0 

Potency (mg) 300.0 

Standard Volume (mL) 100 0 

Sample (mL) 1.5 

! 
I 
I 
Time (hour) Vessel Volume 
0.5 500.0 
1 498.5 
2 497.0 
3 495.5 
6.5 494.0 
7 492.5 
Time (hour) % Dissolved (HPLC) 
0.5 11% 
1 21% 
2 38% 
3 53% 
6.5 88% 
7 95% 
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Figure 7-9 	 HPLC Method Parameters: Single Component and Multi Component 
Experiments 
HPLC Parameters (HP1050) 
• 	 Symmetry 300 C18 5, m column (4.6mm x50 mm), 
• 	 Mobile phase: 60/40/1 (water/methanol/glacial acetic acid), 
• 	 Flow rate: 2.0 mllmin, isocratic mode, Injection volume = 5 IJL 
UV detector was set at 296 nm. 
HPLC Parameters (Waters 26951 
Symmetry Shied RP C18 3IJm column (3.5mmx50 mm) 
Mobile phase 70/30/1 (water/acetonitrile/trifluoroacetic acid (TFA», 
• 	 Flow rate: 1.5 mllmin, isocratic mode, injection volume was 51J1, UV detection was set at 296 nm. 
HPLC Parameters (HP10501 
• 	 Phenomenex Intersil ODS C18 5IJm column (4.6mmx150 mm), 
• 	 Mobile phase: 60/40/1 (methanoVwater/trifluoroacetic acid (TFA», 
• 	 Flow rate: 1.0 mVmin, isocratic mode, injection volume: 251J1 

UV detection was set at 280 nm. 
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Figure 7-10 Typical Excedrin® experiment spectra 
FTIR spedra for Excedrin Caplets 
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Figure 7-11 Excedrin® HPLC Data 
Ret time (min) Area 

Acetaminophen 2,033 190158 

AcetylSalicylic Acid 3.585 9004.3 

Acetaminophen Acetylsalicylic Acid 

10 min 15856.1 8684.1 

20 min 16144.8 8848.6 

30 min 18301.0 9224.6 

1 hour 188684 9341.3 

% Acetaminophen % Acetylsalicylic Acid 
0 0 0 

10 834 964 

20 841 97.3 

30 94.3 100.4 

60 96.2 100.6 
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Appendix [8]: Studying drug kinetics via ATR-IR 
Spectroscopy 
Figure 8-1 Salicylic Acid standard spectra 
ATR·IR Spectra of Salicylic Acid Standard (!l25 me/IOO mL SGF) 
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Figure 8-2 Acetylsalicylic Acid standard spectra 
ATR-IR Spectra of Acetylsalicylic Acid Standard (325 me/1OO mL SGF) 
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Table 8-1 Aspirin FT-IR Frequencies of Interest 
i Wavelength (c-m-') Assignment 
I 2300-2500 carboxylOH 
i 1760 vinyl ester C=O 
• 1690 aromatic acid C=O 
1610 aromatic acid C=O 
1580 aromatic C=C stretch 
1490 aromatic C=C stretch 
1220 =C-O (acid and ester) 
1190 =C-O (acid and ester) 
760 ortho substituted phenyl C-H bending 
[165] 
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Figure 8-3 Rate Order Formulas and Equations (Reproduced from Wikipedia 
website on Rate Order) 
Zero.order Second.order lIih.order 
_ d[A] = k 
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Appendix [C]: New Instrument Design ("Solv-IR") 
attachments 
Figure 9-1 	 ATR-IR Technique Diagram (courtesy of Jian Wang, Ph.D., Mettler 
Toledo) 
[167] 
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~---~-------~~~--~~ 
Appendix [0]: BP Gulf oil research attachments 
Figure 10-1 Detergents used during BP Gulf oil research 
[168] 
100 
Seton Hall University 
Figure 10-2 IR Spectra of Gulf Oil from Riser: Pre- April 20, 2010 
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Table 10·1 Amount of Dawn® dishwashing detergent added 
Time (h:mm) Volume added (ml) Total volume in vessel (ml) 
0:01 1 1 
0:04 1 2 
0:06 1 3 
0:08 3 6 
0:10 3 9 
0:13 3 12 
0:14 3 15 
0:17 3 18 
0:19 3 21 
0:20 3 24 
0:22 3 27 
0:24 3 30 
0:26 3 33 
0:26 3 36 
0:28 3 39 
0:34 3 42 
0:39 3 45 
0:41 3 48 
1:48 3 51 
2:06 3 54 
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Figure 10-3 Thermo Nicolet 4700: % Transmittance of OIL samples 
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Figure 10-4 Thermo Nicolet 4700: Absorbance of OIL samples 
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